Personale

Recapiti

Orario di ricevimento

Italiano

Curriculum

Interessi

Pubblicazioni

Insegnamenti

English

Biography

Curriculum

Interest

Giandomenico ROVIELLO

Ruolo attuale:: Professore Associato
SSD:: MEDS-09/A - Oncologia medica
Afferenza organizzativa:: Dipartimento di Scienze della Salute (DSS)

Recapiti

giandomenico.roviello(AT)unifi.it

Giandomenico ROVIELLO

Curriculum

Dall’Aprile 2023 ad oggi

Professore Associato - SC 06/D3 SSD MED/06, Dipartimento di Scienze della Salute (DSS), Università degli Studi di Firenze

Dall’Aprile 2020 al Marzo 2022

Ricercatore a tempo determinato di tipologia b) - SC 06/D3 SSD MED/06, Dipartimento di Scienze della Salute (DSS), Università degli Studi di Firenze

Dal Febbraio 2019 al Marzo 2020

Ricercatore a tempo determinato di tipologia a) - SC 06/D3 SSD MED/06, Dipartimento di Scienze della Salute (DSS), Università degli Studi di Firenze

Dal Novembre 2022 ad oggi

Dirigente medico di I livello presso SOD Oncologia clinica, AOU Careggi, Firenze (FI)

Dal Febbraio 2019 ad Ottobre 2022

Dirigente medico di I livello presso SOD Oncologia traslazionale, AOU Careggi, Firenze (FI)

Dal Settembre 2018 a Gennaio 2019

Dirigente Medico di I livello con contratto a tempo determinato presso l’Unità Operativa di Oncologia Medica, Azienda Sanitaria Universitaria Integrata di Trieste, Trieste (TS)

Dal Gennaio 2018 ad Agosto 2018

Dirigente Medico di I livello con contratto a tempo determinato presso l’Unità Operativa di Oncologia Medica, IRCCS CROB, Rionero in Vulture (PZ)

Dal Luglio 2017 a Dicembre 2017

Incarico di Specialistica ambulatoriale presso la Clinica di Oncologia Medica, Ospedale San Donato, Arezzo

Dal Settembre 2016 a Giugno 2017

Borsista di ricerca per il progetto: “Sanità di Genere in ambito oncologico: prevenzione, trattamento e riabilitazione delle patologie oncologiche correlate al genere. Approcci innovativi per una Sanità di Genere”. Clinica di Oncologia Medica, Ospedale San Donato, Arezzo

Dal Settembre 2015 ad Agosto 2016

Assegnista di ricerca per l’Università degli Studi di BRESCIA, Dipartimento MEDICINA MOLECOLARE E TRASLAZIONALE, U.O. Multidisciplinare di Patologia Mammaria, ASST Cremona

Dal Maggio 2010 a Giugno 2015

Medico in formazione specialistica in oncologia medica presso l’unità operativa di Oncologia medica (Prof. Francini) dell’università degli studi di Siena

Dal Febbraio 2010 ad Aprile 2010

Medico interno presso l’unità operativa di Oncologia medica (Prof. Francini) dell’università degli studi di Siena

Dal Settembre 2008 a Maggio 2009

Medico interno presso l’unità operativa di Ematologia (Dott. Guastafierro) della Università degli Studi della Campania "Luigi Vanvitelli"

Istruzione e formazione

Novembre 2021-Maggio 2022

Università di Padova

Master di I Livello in Biostatistica per la Ricerca Clinica e la Pubblicazione Scientifica

Gennaio 2020-Gennaio 2021

Università di Roma La Sapienza

Master di II livello in Immuno Oncologia

Settembre 2016- Settembre 2019

Università di Trieste,

Dottorato in Biomedicina Molecolare

Maggio 2010-Giugno 2015

Università di Siena

Diploma di specializzazione in Oncologia medica conseguito con 70/70 e Lode

Marzo 2014-Ottobre 2015

Università degli Studi di Modena e Reggio Emilia

Corso di perfezionamento in Revisioni Sistematiche e Meta-Analisi Cochrane

Marzo 2011- Gennaio 2012

Università degli Studi di Modena e Reggio Emilia

Corso di perfezionamento in Statistica Applicata ai Quesiti Clinici

Settembre 2002-Luglio 2008

Università degli Studi della Campania "Luigi Vanvitelli"

Laurea Specialistica in Medicina e Chirurgia

Settembre 1997- Giugno 2001

Diploma di Maturità Scientifica

Liceo Scientifico “Armando Diaz”, Caserta (CE)

Giandomenico ROVIELLO

Pubblicazioni

Legenda

Contributo su rivista |

Articolo su libro |

Libro |

Contributo in atti di convegno (proceeding) |

Brevetto |

Curatela | Altro

Altro |

Tesi di Dottorato

Matteo Lulli, Andrea Trabocchi, Giandomenico Roviello, Martina Catalano, Laura Papucci, Astrid Parenti, Alice Molli, Cristina Napoli, Ida Landini, Nicola Schiavone, Andrea Lapucci (2024). Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells. FRONTIERS IN PHARMACOLOGY, pp. 0-0, ISSN:1663-9812 DOI

Perrone, Gabriele; Rigacci, Luigi; Roviello, Giandomenico; Landini, Ida; Fabbri, Alberto; Iovino, Lorenzo; Puccini, Benedetta; Cencini, Emanuele; Orciuolo, Enrico; Bocchia, Monica; Bosi, Alberto; Mini, Enrico; Nobili, Stefania (2024). Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients. CANCER DRUG RESISTANCE, vol. 7, pp. 1-14, ISSN:2578-532X DOI

Sun, Liyang; Wang, Xueting; Zhou, Huimin; Li, Rui; Meng, Ming; Roviello, Giandomenico; Oh, Byeongsang; Feng, Lingxin; Yu, Zhuang; Wang, Jing (2024). Gut microbiota and metabolites associated with immunotherapy efficacy in extensive-stage small cell lung cancer: a pilot study. JOURNAL OF THORACIC DISEASE, vol. 16, pp. 6936-6954, ISSN:2072-1439 DOI

Catalano, Martina; Fancelli, Sara; Caliman, Enrico; Mazzoni, Francesca; Michelet, Marta Gatta; Mancini, Silvia; Manneschi, Clara; Shabani, Sonia; Napolitano, Brunella; Pillozzi, Serena; Antonuzzo, Lorenzo; Roviello, Giandomenico (2024). Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors. SCIENTIFIC REPORTS, vol. 14, pp. 1-9, ISSN:2045-2322 DOI Accesso ONLINE all'editore

Nozzoli, Filippo; Nassini, Romina; De Logu, Francesco; Catalano, Martina; Roviello, Giandomenico; Massi, Daniela (2024). Reconceiving Perineural Invasion in Cutaneous Squamous Cell Carcinoma: From Biological to Histopathological Assessment. PATHOBIOLOGY, vol. -, pp. 1-13, ISSN:1015-2008 DOI

Catalano, Martina; Nozzoli, Filippo; De Logu, Francesco; Nassini, Romina; Roviello, Giandomenico (2024). Management Approaches for High-Risk Cutaneous Squamous Cell Carcinoma with Perineural Invasion: An Updated Review. CURRENT TREATMENT OPTIONS IN ONCOLOGY, vol. -, pp. 1-9, ISSN:1527-2729 DOI

Massari, Francesco; Santoni, Matteo; Takeshita, Hideki; Okada, Yohei; Tapia, Jose Carlos; Basso, Umberto; Maruzzo, Marco; Scagliarini, Sarah; Büttner, Thomas; Fornarini, Giuseppe; Myint, Zin W.; Galli, Luca; Souza, Vinicius Carrera; Pichler, Renate; De Giorgi, Ugo; Gandur, Nathalia; Lam, Elaine T.; Gilbert, Danielle; Popovic, Lazar; Grande, Enrique; Mammone, Giulia; Berardi, Rossana; Crabb, Simon J.; Kemp, Robert; Molina-Cerrillo, Javier; Freitas, Marcelo; Luz, Murilo; Iacovelli, Roberto; Calabrò, Fabio; Tural, Deniz; Atzori, Francesco; Küronya, Zsófia; Chiari, Rita; Campos, Saul; Caffo, Orazio; Fay, André P.; Kucharz, Jakub; Zucali, Paolo Andrea; Rinck, José Augusto; Zeppellini, Annalisa; Bastos, Diogo Assed; Aurilio, Gaetano; Mota, Augusto; Trindade, Karine; Ortega, Cinzia; Sade, Juan Pablo; Rizzo, Mimma; Fiala, Ondřej; Vau, Nuno; Giannatempo, Patrizia; Barillas, Allan; Monteiro, Fernando Sabino M.; Dauster, Breno; Mennitto, Alessia; Nogueira, Lucas; de Carvalho Fernandes, Roni; Seront, Emmanuel; Aceituno, Luís Garcia; Grillone, Francesco; Cutuli, Hernan Javier; Fernandez, Mauricio; Bassanelli, Maria; Kopp, Ray Manneh; Roviello, Giandomenico; Abahssain, Halima; Procopio, Giuseppe; Milella, Michele; Kopecky, Jindrich; Martignetti, Angelo; Messina, Carlo; Caitano, Manuel; Inman, Eva; Kanesvaran, Ravindran; Herchhorn, Daniel; Santini, Daniele; Bamias, Aristotelis; Bisonni, Renato; Mosca, Alessandra; Morelli, Franco; Maluf, Fernando; Soares, Andrey; Nunes, Fernando; Pinto, Alvaro; Zgura, Anca; Incorvaia, Lorena; Ansari, Jawaher; Zabalza, Ignacio Ortego; Landmesser, Johannes; Rizzo, Alessandro; Mollica, Veronica; Marchetti, Andrea; Rosellini, Matteo; Sorgentoni, Giulia; Battelli, Nicola; Buti, Sebastiano; Porta, Camillo; Bellmunt, Joaquim (2024). Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study. CANCER IMMUNOLOGY, IMMUNOTHERAPY, vol. 73, pp. 0-0, ISSN:1432-0851 DOI

Fiala, Ondřej; Massari, Francesco; Basso, Umberto; Giannatempo, Patrizia; Grande, Enrique; Buti, Sebastiano; Myint, Zin W.; De Giorgi, Ugo; Pichler, Renate; Grillone, Francesco; Ürün, Yüksel; Calabrò, Fabio; Bourlon, Maria T.; Galli, Luca; Kanesvaran, Ravindran; Roviello, Giandomenico; Kucharz, Jakub; Rizzo, Mimma; Park, Se Hoon; Cerbone, Linda; Seront, Emmanuel; Messina, Carlo; Molina-Cerrillo, Javier; Santini, Daniele; Yano, Akihiro; Incorvaia, Lorena; Catalano, Martina; Pinto, Alvaro; Formisano, Luigi; Soares, Andrey; Facchini, Gaetano; Fornarini, Giuseppe; Poprach, Alexandr; Rebuzzi, Sara Elena; Nasso, Cecilia; Spinelli, Gian Paolo; Angel, Martin; Stellato, Marco; Tural, Deniz; Aurilio, Gaetano; Epstein, Ilana; Carrozza, Francesco; Monteiro, Fernando Sabino Marques; Benedetti, Giovanni; Büchler, Tomáš; Ortega, Cinzia; Zakopoulou, Roubini; Battelli, Nicola; Porta, Camillo; Bellmunt, Joaquin; Gupta, Shilpa; Santoni, Matteo (2024). Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study. TARGETED ONCOLOGY, vol. -, pp. 1-11, ISSN:1776-2596 DOI

Santini, Daniele; Li, Haoran; Roviello, Giandomenico; Park, Se Hoon; Grande, Enrique; Kucharz, Jakub; Basso, Umberto; Fiala, Ondrej; Monteiro, Fernando Sabino Marques; Poprach, Alexandr; Buti, Sebastiano; Molina-Cerrillo, Javier; Catalano, Martina; Buchler, Tomas; Seront, Emmanuel; Ansari, Jawaher; Myint, Zin W.; Ghosn, Marwan; Calabrò, Fabio; Kopp, Ray Manneh; Bhuva, Dipen; Bourlon, Maria T.; Roberto, Michela; Di Civita, Mattia Alberto; Mollica, Veronica; Marchetti, Andrea; Soares, Andrey; Battelli, Nicola; Ricci, Marco; Kanesvaran, Ravindran; Bamias, Aristotelis; Porta, Camillo; Massari, Francesco; Santoni, Matteo (2024). Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1). TARGETED ONCOLOGY, vol. -, pp. 1-11, ISSN:1776-2596 DOI

Morgagni, Paolo; Bencivenga, Maria; Carneiro, Fatima; Cascinu, Stefano; Derks, Sarah; Di Bartolomeo, Maria; Donohoe, Claire; Eveno, Clarisse; Gisbertz, Suzanne; Grimminger, Peter; Gockel, Ines; Grabsch, Heike; Kassab, Paulo; Langer, Rupert; Lonardi, Sara; Maltoni, Marco; Markar, Sheraz; Moehler, Markus; Marrelli, Daniele; Mazzei, Maria Antonietta; Melisi, Davide; Milandri, Carlo; Moenig, Paul Stefan; Mostert, Bianca; Mura, Gianni; Polkowski, Wojciech; Reynolds, John; Saragoni, Luca; Van Berge Henegouwen, Mark I.; Van Hillegersberg, Richard; Vieth, Michael; Verlato, Giuseppe; Torroni, Lorena; Wijnhoven, Bas; Tiberio, Guido Alberto Massimo; Yang, Han-Kwang; Roviello, Franco; de Manzoni, Giovanni; Giandomenico, Roviello (2024). Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape. GASTRIC CANCER, vol. 27, pp. 649-671, ISSN:1436-3291 DOI

Cursano, M.C.; Valsecchi, A.A.; Pantano, F.; Di Maio, M.; Procopio, G.; Berruti, A.; Bertoldo, F.; Tucci, M.; De Giorgi, U.; Santini, D.; Altavilla, Amelia; Atzori, Francesco; Banna, Giuseppe Luigi; Barni, Sandro; Basso, Umberto; Bauckneht, Matteo; Berardi, Rossana; Berruti, Alfredo; Bertoldo, Francesco; Bimbatti, Davide; Boccardo, Francesco; Buti, Sebastiano; Buttigliero, Consuelo; Caffo, Orazio; Calabrò, Fabio; Cattrini, Carlo; Cellini, Francesco; Conteduca, Vincenza; Cursano, Maria Concetta; De Feo, Giulia; De Giorgi, Ugo; Di Lorenzo, Giuseppe; Di Maio, Massimo; Di Napoli, Marilena; Ermacora, Paola; Fornarini, Giuseppe; Fratino, Lucia; Fusco, Vittorio; Gernone, Angela; Ibrahim, Toni; Lanzetta, Gaetano; Malgeri, Andrea; Maruzzo, Marco; Masini, Cristina; Messina, Carlo; Mosca, Alessandra; Naglieri, Emanuele; Nolè, Franco; Ortega, Cinzia; Palermo, Andrea; Pantano, Francesco; Prati, Veronica; Procopio, Giuseppe; Rescigno, Pasquale; Roberto, Michela; Rossetti, Sabrina; Roviello, Giandomenico; Santini, Daniele; Stellato, Marco; Tambaro, Rosa; Toma, Ilaria; Tucci, Marcello; Valsecchi, Anna Amela; Verzoni, Elena; Zanardi, Elisa; Zucali, Paolo Andrea (2024). Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies. ESMO OPEN, vol. 9, pp. 1-31, ISSN:2059-7029 DOI

Rizzo, Alessandro; Monteiro, Fernando Sabino Marques; Ürün, Yüksel; Massari, Francesco; Park, Se Hoon; Bourlon, Maria T.; Poprach, Alexandr; Rizzo, Mimma; Takeshita, Hideki; Giannatempo, Patrizia; Soares, Andrey; Roviello, Giandomenico; Molina-Cerrillo, Javier; Carrozza, Francesco; Abahssain, Halima; Messina, Carlo; Kopp, Ray Manneh; Pichler, Renate; Formisano, Luigi; Tural, Deniz; Atzori, Francesco; Calabrò, Fabio; Kanesvaran, Ravindran; Buti, Sebastiano; Santoni, Matteo (2024). Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project. TARGETED ONCOLOGY, pp. 1-9, ISSN:1776-2596 DOI

Mu, Yi; Dong, Yinan; Zheng, Mingyang; Barr, Martin P.; Roviello, Giandomenico; Hu, Zhihuang; Liu, Jia (2024). Identification of a prognostic gene signature in patients with cisplatin resistant squamous cell lung cancer. JOURNAL OF THORACIC DISEASE, vol. 16, pp. 4567-4583, ISSN:2072-1439 DOI

Damassi, Alessandra; Cremante, Malvina; Signori, Alessio; Rebuzzi, Sara Elena; Malgeri, Andrea; Napoli, Marilena Di; Caffo, Orazio; Vignani, Francesca; Cavo, Alessia; Roviello, Giandomenico; Prati, Veronica; Tudini, Marianna; Atzori, Francesco; Messina, Marco; Morelli, Franco; Prati, Giuseppe; Nolè, Franco; Catalano, Fabio; Murianni, Veronica; Rescigno, Pasquale; Banna, Giuseppe Luigi; Fornarini, Giuseppe; Buti, Sebastiano (2024). Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab. IMMUNOTHERAPY, pp. 1-9, ISSN:1750-743X DOI

Ciccarese, Chiara; Büttner, Thomas; Cerbone, Linda; Zampiva, Ilaria; Monteiro, Fernando Sabino M.; Basso, Umberto; Pichler, Martin; Vitale, Maria Giuseppa; Fiala, Ondrej; Roviello, Giandomenico; Kopp, Ray Manneh; Carrozza, Francesco; Pichler, Renate; Grillone, Francesco; Calabuig, Esther Pérez; Zeppellini, Annalisa; Küronya, Zsófia; Galli, Luca; Facchini, Gaetano; Sunela, Kaisa; Mosca, Alessandra; Molina‐Cerrillo, Javier; Spinelli, Gian Paolo; Ansari, Jawaher; Scala, Alessandro; Mollica, Veronica; Grande, Enrique; Buti, Sebastiano; Kanesvaran, Ravindran; Zakopoulou, Roubini; Bamias, Aristotelis; Rizzo, Mimma; Massari, Francesco; Iacovelli, Roberto; Santoni, Matteo (2024). Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de‐differentiation (ARON‐1 study). INTERNATIONAL JOURNAL OF CANCER, vol. -, pp. 1-11, ISSN:0020-7136 DOI

Rizzo, Mimma; Soares, Andrey; Grande, Enrique; Bamias, Aristotelis; Kopp, Ray Manneh; Lenci, Edoardo; Buttner, Thomas; Salah, Samer; Grillone, Francesco; de Carvalho, Icaro Thiago; Tapia, Jose Carlos; Gucciardino, Calogero; Pinto, Alvaro; Mennitto, Alessia; Abahssain, Halima; Rescigno, Pasquale; Myint, Zin; Takeshita, Hideki; Spinelli, Gian Paolo; Popovic, Lazar; Vitale, Maria Giuseppa; Fiala, Ondrej; Giannatempo, Patrizia; Zakopoulou, Roubini; Carrozza, Francesco; Massari, Francesco; Monteiro, Fernando Sabino Marques; Pace, Maria Paola; Giannini, Massimo; Roviello, Giandomenico; Porta, Camillo; Battelli, Nicola; Kanesvaran, Ravindran; Santoni, Matteo (2024). Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study. SCIENTIFIC REPORTS, vol. 14, pp. 1-11, ISSN:2045-2322 DOI

Buti, Sebastiano; Olivari, Alessandro; Masini, Cristina; Bimbatti, Davide; Sartori, Donata; Ermacora, Paola; Cattrini, Carlo; Vitale, Maria Giuseppa; Rossi, Ernesto; Mucciarini, Claudia; Rizzo, Mimma; Sisani, Michele; Santoni, Matteo; Roviello, Giandomenico; Mollica, Veronica; Conteduca, Vincenza; Grillone, Francesco; Cinausero, Marika; Prati, Giuseppe; Atzori, Francesco; Stellato, Marco; Massari, Francesco; Bersanelli, Melissa (2024). Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study’s analysis of heavily pretreated patients. THERAPEUTIC ADVANCES IN UROLOGY, vol. 16, pp. 0-0, ISSN:1756-2872 DOI

Nozzoli, Filippo; Catalano, Martina; Messerini, Luca; Cianchi, Fabio; Nassini, Romina; De Logu, Francesco; Iannone, Luigi Francesco; Ugolini, Filippo; Simi, Sara; Massi, Daniela; Geppetti, Pierangelo; Roviello, Giandomenico (2024). Perineural invasion score system and clinical outcomes in resected pancreatic cancer patients. PANCREATOLOGY, vol. -, pp. 1-9, ISSN:1424-3903 DOI

Laurino, Simona; Russi, Sabino; Omer, Ludmila Carmen; D'Angelo, Alberto; Bozza, Giovanni; Gallucci, Giuseppina; Falco, Geppino; Roviello, Giandomenico; Bochicchio, Anna Maria (2024). The Conundrum of Cancer-Associated Thrombosis: Lesson Learned from Two Intriguing Cases and Literature Review. DISEASES, vol. 12, pp. 1-9, ISSN:2079-9721 DOI

Maiorano, Brigida Anna; Di Maio, Massimo; Cerbone, Linda; Maiello, Evaristo; Procopio, Giuseppe; Roviello, Giandomenico (2024). Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. JAMA NETWORK OPEN, vol. 7, pp. 0-0, ISSN:2574-3805 DOI

Murianni, Veronica; Signori, Alessio; Buti, Sebastiano; Rebuzzi, Sara Elena; Bimbatti, Davide; De Giorgi, Ugo; Chiellino, Silvia; Galli, Luca; Zucali, Paolo Andrea; Masini, Cristina; Naglieri, Emanuele; Procopio, Giuseppe; Milella, Michele; Fratino, Lucia; Baldessari, Cinzia; Ricotta, Riccardo; Mollica, Veronica; Sorarù, Mariella; Tudini, Marianna; Prati, Veronica; Malgeri, Andrea; Atzori, Francesco; Di Napoli, Marilena; Caffo, Orazio; Spada, Massimiliano; Morelli, Franco; Prati, Giuseppe; Nolè, Franco; Vignani, Francesca; Cavo, Alessia; Lipari, Helga; Roviello, Giandomenico; Catalano, Fabio; Damassi, Alessandra; Cremante, Malvina; Rescigno, Pasquale; Fornarini, Giuseppe; Banna, Giuseppe Luigi (2024). Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study. FRONTIERS IN ONCOLOGY, vol. 14, pp. 1-9, ISSN:2234-943X DOI

Catalano, Martina; De Giorgi, Ugo; Bimbatti, Davide; Buti, Sebastiano; Procopio, Giuseppe; Sepe, Pierangela; Santoni, Matteo; Galli, Luca; Conca, Raffaele; Doni, Laura; Antonuzzo, Lorenzo; Roviello, Giandomenico (2024). Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or Pazopanib. CLINICAL GENITOURINARY CANCER, pp. 0-0, ISSN:1558-7673 DOI

Incorvaia, Lorena; Monteiro, Fernando Sabino Marques; Massari, Francesco; Park, Se Hoon; Roviello, Giandomenico; Fiala, Ondřej; Myint, Zin W.; Kucharz, Jakub; Molina-Cerrillo, Javier; Santini, Daniele; Buttner, Thomas; Poprach, Alexandr; Kopecky, Jindrich; Zeppellini, Annalisa; Pichler, Martin; Buchler, Tomas; Pichler, Renate; Facchini, Gaetano; Fay, Andre Poisl; Soares, Andrey; Manneh, Ray; Iezzi, Laura; Kuronya, Zsofia; Russo, Antonio; Bourlon, Maria T.; Bhuva, Dipen; Ansari, Jawaher; Kanesvaran, Ravindran; Grande, Enrique; Buti, Sebastiano; Santoni, Matteo (2024). Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations. CANCER IMMUNOLOGY, IMMUNOTHERAPY, vol. 73, pp. 1-12, ISSN:1432-0851 DOI

Gambale, Elisabetta; Maruzzo, Marco; Messina, Carlo; De Gennaro Aquino, Irene; Vascotto, Ismaela Anna; Rossi, Virginia; Bimbatti, Davide; Cavasin, Nicolò; Messina, Marco; Mennitto, Alessia; Rebuzzi, Sara Elena; Nasso, Cecilia; Mercinelli, Chiara; Maiorano, Brigida Anna; Fanelli, Martina; Sorarù, Mariella; Scolari, Federico; Mela, Marinella Micol; Galli, Luca; Salfi, Alessia; Rizzo, Mimma; Puglisi, Silvia; Orlando, Valentina; Fornarini, Giuseppe; Rametta, Alessandro; Giannatempo, Patrizia; Cerbone, Linda; Doni, Laura; Roviello, Giandomenico; Pillozzi, Serena; Antonuzzo, Lorenzo (2024). Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25). CLINICAL GENITOURINARY CANCER, vol. 22, pp. 1-11, ISSN:1558-7673 DOI

Paolieri, Federico; Sammarco, Enrico; Ferrari, Marco; Salfi, Alessia; Bonato, Adele; Serafin, Debora; Coccia, Natalia; Manfredi, Fiorella; Zatteri, Luca; Dima, Giovanni; Carli, Chiara; Di Vita, Rosanna; Oliveri, Maria; Doni, Laura; Galli, Luca; Sisani, Michele; Catalano, Martina; Roviello, Giandomenico; Bloise, Francesco (2024). Front-Line Therapeutic Strategy in Metastatic Hormone Sensitive Prostate Cancer: An Updated Therapeutic Algorithm. CLINICAL GENITOURINARY CANCER, vol. 22, pp. 0-0, ISSN:1938-0682 DOI

Santoni, Matteo; Buti, Sebastiano; Myint, Zin W.; Maruzzo, Marco; Iacovelli, Roberto; Pichler, Martin; Kopecky, Jindrich; Kucharz, Jakub; Rizzo, Mimma; Galli, Luca; Büttner, Thomas; De Giorgi, Ugo; Kanesvaran, Ravindran; Fiala, Ondřej; Grande, Enrique; Zucali, Paolo Andrea; Kopp, Ray Manneh; Fornarini, Giuseppe; Bourlon, Maria T.; Scagliarini, Sarah; Molina-Cerrillo, Javier; Aurilio, Gaetano; Matrana, Marc R.; Pichler, Renate; Cattrini, Carlo; Büchler, Tomas; Massari, Francesco; Seront, Emmanuel; Calabrò, Fabio; Pinto, Alvaro; Berardi, Rossana; Zgura, Anca; Mammone, Giulia; Ansari, Jawaher; Atzori, Francesco; Chiari, Rita; Bamias, Aristotelis; Caffo, Orazio; Procopio, Giuseppe; Sunela, Kaisa; Bassanelli, Maria; Ortega, Cinzia; Grillone, Francesco; Landmesser, Johannes; Milella, Michele; Messina, Carlo; Küronya, Zsófia; Mosca, Alessandra; Bhuva, Dipen; Santini, Daniele; Vau, Nuno; Morelli, Franco; Incorvaia, Lorena; Rebuzzi, Sara Elena; Roviello, Giandomenico; Soares, Andrey; Bisonni, Renato; Bimbatti, Davide; Zabalza, Ignacio Ortego; Rizzo, Alessandro; Mollica, Veronica; Sorgentoni, Giulia; Monteiro, Fernando Sabino M.; Battelli, Nicola; Bracarda, Sergio; Porta, Camillo (2024). Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?. EUROPEAN UROLOGY ONCOLOGY, vol. 7, pp. 102-111, ISSN:2588-9311 DOI

Bloise, Francesco; Manfredi, Fiorella; Zatteri, Luca; Dima, Giovanni; Carli, Chiara; Di Vita, Rosanna; Olivieri, Maria; Sammarco, Enrico; Ferrari, Marco; Salfi, Alessia; Bonato, Adele; Serafin, Debora; Coccia, Natalia; Doni, Laura; Galli, Luca; Sisani, Michele; Roviello, Giandomenico; Catalano, Martina; Paolieri, Federico (2024). First-Line Treatments and Management of Metastatic Renal Cell Carcinoma Patients: An Italian Interdisciplinary Uro-Oncologic Group Algorithm. CELLS, vol. 13, pp. 1-13, ISSN:2073-4409 DOI

Catalano, Martina; Santoni, Matteo; Roviello, Giandomenico (2024). Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer. EUROPEAN UROLOGY, pp. 1-1, ISSN:0302-2838 DOI

Roviello, Giandomenico; Vascotto, Ismaela Anna; Catalano, Martina (2024). Editorial: Analysis of tumor immune microenvironments and molecular mechanism to reveal the dilemma of immunotherapy for advanced non-small cell lung cancer. FRONTIERS IN IMMUNOLOGY, vol. 15, pp. 1-3, ISSN:1664-3224 DOI

Roviello, Giandomenico; Santoni, Matteo; Sonpavde, Guru P.; Catalano, Martina (2024). The evolving treatment landscape of metastatic urothelial cancer. NATURE REVIEWS. UROLOGY, pp. 0-0, ISSN:1759-4812 DOI

Catalano, Martina; Rebuzzi, Sara Elena; Maruzzo, Marco; De Giorgi, Ugo; Buti, Sebastiano; Galli, Luca; Fornarini, Giuseppe; Zucali, Paolo Andrea; Claps, Melanie; Chiellino, Silvia; Zampiva, Ilaria; Pipitone, Stefania; Ricotta, Riccardo; Sorarù, Mariella; Mollica, Veronica; Tudini, Marianna; Fratino, Lucia; Prati, Veronica; Caffo, Orazio; Atzori, Francesco; Morelli, Franco; Prati, Giuseppe; Nolè, Franco; Vignani, Francesca; Cavo, Alessia; Di Napoli, Marilena; Malgeri, Andrea; Naglieri, Emanuele; Signori, Alessio; Banna, Giuseppe Luigi; Rescigno, Pasquale; Cerbone, Linda; Antonuzzo, Lorenzo; Roviello, Giandomenico (2024). Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study. FRONTIERS IN IMMUNOLOGY, vol. 15, pp. 1-11, ISSN:1664-3224 DOI

Messina, Carlo; Catalano, Martina; Roviello, Giandomenico; Gandini, Annalice; Maruzzo, Marco; De Giorgi, Ugo; Pedrazzoli, Paolo; Sbrana, Andrea; Zucal, Paolo Andrea; Masini, Cristina; Naglieri, Emanuele; Procopio, Giuseppe; Milella, Michele; Catalano, Fabio; Fratino, Lucia; Pipitone, Stefania; Ricotta, Riccardo; Panni, Stefano; Mollica, Veronica; Soraru, Mariella; Prati, Veronica; Atzori, Francesco; Di Napoli, Marilena; Messina, Marco; Morelli, Franco; Prati, Giuseppe; Nole, Franco; Malgeri, Andrea; Tudini, Marianna; Vignani, Francesca; Cavo, Alessia; Signori, Alessio; Banna, Giuseppe Luigi; Rescigno, Pasquale; Buti, Sebastiano; Rebuzzi, Sara Elena; Fornarini, Giuseppe (2024). Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study. CANCER IMMUNOLOGY, IMMUNOTHERAPY, vol. 73, pp. 1-8, ISSN:1432-0851 DOI

Mollica, Veronica; Massari, Francesco; Maruzzo, Marco; Bimbatti, Davide; Claps, Melanie; Maiorano, Brigida Anna; Vitale, Maria Giuseppa; Iacovelli, Roberto; Ermacora, Paola; Roviello, Giandomenico; Calabrò, Fabio; Caffo, Orazio; Vignani, Francesca; Grillone, Francesco; Pierantoni, Francesco; Di Napoli, Marilena; Mennitto, Alessia; Marchetti, Andrea; Mattana, Alvise; Cavo, Alessia; Bassanelli, Maria; Formisano, Luigi; Prati, Veronica; Giudice, Giulia Claire; Buti, Sebastiano (2024). Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study. CLINICAL GENITOURINARY CANCER, vol. 18, pp. 1-13, ISSN:1938-0682 DOI

Stellato, Marco; Buti, Sebastiano; Maruzzo, Marco; Bassanelli, Maria; Bersanelli, Melissa; Napoli, Marilena Di; Dionese, Michele; Fanelli, Martina; Filippi, Roberto; Fotia, Giuseppe; Galli, Luca; Grillone, Francesco; Maffezzoli, Michele; Maiorano, Brigida Anna; Nasso, Cecilia; Rebuzzi, Sara Elena; Lalli, Luca; Roviello, Giandomenico; Sorarù, Mariella; Vincenzi, Bruno; Procopio, Giuseppe; Verzoni, Elena (2024). Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27. CLINICAL GENITOURINARY CANCER, vol. 22, pp. 1-13, ISSN:1558-7673 DOI

Giunta, Emilio Francesco; Roviello, Giandomenico; Conteduca, Vincenza; Verzoni, Elena; Procopio, Giuseppe; De Giorgi, Ugo (2024). Pharmacological treatment landscape of non-metastatic hormone-sensitive prostate cancer: A narrative review on behalf of the meet-URO Group. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 204, pp. 1-7, ISSN:1040-8428 DOI

Maiorano, Brigida Anna; Catalano, Martina; Maiello, Evaristo; Roviello, Giandomenico (2023). Enfortumab vedotin in metastatic urothelial carcinoma: the solution EVentually?. FRONTIERS IN ONCOLOGY, vol. 13, pp. 1-7, ISSN:2234-943X DOI

Perrone, Gabriele; Rigacci, Luigi; Urru, Sara; Kovalchuk, Sofya; Brugia, Marco; Fabbri, Alberto; Iovino, Lorenzo; Puccini, Benedetta; Cencini, Emanuele; Orciuolo, Enrico; Birtolo, Silvia; Melosi, Alessandro; Santini, Simone; Landini, Ida; Roviello, Giandomenico; Santi, Raffaella; Macciotta, Alessandra; Ricceri, Fulvio; Bosi, Alberto; Bocchia, Monica; Petrini, Mario; Mini, Enrico; Nobili, Stefania (2023). Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma. CANCERS, vol. 15, pp. 0-0, ISSN:2072-6694 DOI

Maiorano, Brigida Anna; Ciardiello, Davide; Maiello, Evaristo; Roviello, Giandomenico (2023). Comparison of Anti–Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis. JAMA NETWORK OPEN, vol. 6, pp. 1-3, ISSN:2574-3805 DOI

D'Angelo, Alberto; Catalano, Martina; Conca, Raffaele; Petrioli, Roberto; Siminonato, Francesca; Cappetta, Alessandro; Roviello, Giandomenico; Ramello, Monica (2023). Clinical outcome and safety profile of metastatic pancreatic cancer patients treated with more than six cycles of nab-paclitaxel plus gemcitabine. JOURNAL OF CHEMOTHERAPY, vol. 35, pp. 753-759, ISSN:1120-009X DOI

Lavacchi, Daniele; Fancelli, Sara; Buttitta, Eleonora; Vannini, Gianmarco; Guidolin, Alessia; Winchler, Costanza; Caliman, Enrico; Vannini, Agnese; Giommoni, Elisa; Brugia, Marco; Cianchi, Fabio; Pillozzi, Serena; Roviello, Giandomenico; Antonuzzo, Lorenzo (2023). Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 24, pp. 1-18, ISSN:1422-0067 DOI Accesso ONLINE all'editore

Marano L.; Marmorino F.; Desideri I.; Carbone L.; Rizzo A.; Salvestrini V.; Roviello F.; Cinieri S.; Donato V.; De Luca R.; Sofia S.; Milone M.; Ielpo B.; Mita M.T.; Ministrini S.; Giuffrida M.; Tutino R.; Baldi C.; Perri G.; Lippolis A.S.; Marafante C.; Giannandrea G.; Marino M.V.; Laface L.; Di Saverio S.; Aldrighetti L.; De'angelis N.; Salimian N.; Caricato M.; Pellino G.; Vertaldi S.; Cipriani F.; Capolupo G.T.; Costanzo A.; Santandrea L.; Gallo G.; Belli A.; Mastrangelo L.; Rosa F.; Pecorelli N.; Marino G.; Giordano A.; Cillara N.; Lemma M.; Pata F.; Cammillini F.; Poto G.E.; Grassi G.; Altomare D.F.; Picciariello A.; Petagna L.; Ippolito L.; Treppiedi E.; Delogu D.; Moukachar A.; Granieri S.; Cuticone G.; Samorani O.C.; Rega D.; Solaini L.; de Pascale S.; Ascari F.; Manigrasso M.; Badalucco S.; Paiella S.; Coppola S.; Iadarola R.; Di Meo G.; Montroni I.; Vistoli F.; Ferraro V.; Saladino E.; Fazio F.; Rota R.; Orlando F.; Famularo S.; Bizzoca C.; Dalmonte G.; Inama M.; Verre L.; Siragusa L.; Gianmaria C.P.; Benedetti M.; Tamini N.; Conti C.; Ammerata G.; Mantova S.; Pinto V.L.; Corvasce A.; Micheletti G.; Perra T.; Pellicciaro M.; Materazzo M.; Zuolo M.; Doria E.; Brillantino A.; Del Prete L.; Muratore A.; Luciani C.; Turri G.; Casciani F.; Giuseppe G.; Barile G.; Oldra G.; Restaino V.; Deidda S.; Ammendola M.; Bucci A.F.; Marsanic P.; Cassetti D.; Resca L.; Fusario D.; Andreucci E.; Michelotti A.; Amoruso B.; Franco I.; Noto L.; Spallanzani A.; Scalia R.C.; Del Giudice T.; Merz V.; Motta G.; Parisi A.; Modesti M.; Argentiero A.; Basile D.; Vannini G.; Ottanelli C.; Corallo S.; Lutrino E.S.; Rossini D.; Morano F.; Stucci L.S.; Winchler C.; Catalano M.; Marini A.; Brisinda G.; Sammarco E.; Carullo M.; Roviello G.; Barone M.; Rodriquenz M.G.; Tirino G.; Amoruso A.; Russo A.; Conca V.; Orgiano L.; Macrini S.; Nazzicone G.; Bensi M.; Montesano M.; Dell'aquila E.; Sbrana A.; Borelli B.; Fornaro L.; Raimondi L.; Zurlo V.; Garutti M.; Ongaro E.; Pellegrino A.; Lanese A.; Bernardini L.; Boccaccino A.; Farina P.; Buzzacchino F.; Petrillo A.; Taravella A.; Studiale V.; Ciraci P.; Lovino G.; Di Cosmo D.; Montrone S.; Gregucci F.; Dominici L.; Fiorentino A.; Carannante F.; Siepe G.; Montesi G.; Roghi M.; Aquilano M.; Romei A.; Bonaparte I.; Grassi R.; D'ippolito E.; Frosini G.; De Marco G.; Giovine G.; Mattioli C.; Morelli I.; Lorenzetti V.; Mariotti M.; Orsatti C.; Troncone V.; Livi L.; Angrisani A.; Banini M.; Di Pietro T.; Iorio G.C.; Cavallo I.; Cerbai C.; Nardone V.; De Felice F.; Rosa C.; Stocchi G.; Lucidi S.; Ganovelli M.; Dei D.; Cascone C.; Peru A.; Caprara L.; Angelini L.; Visani L.; Francolini G.; Bettazzi B.; Belia F.; Boccardi V.; Serafini S.; Bottino V.; Ferrario L.; Frazzetta G.; Pirozzi F.; Martines G.; Ciarleglio F.A.; Indiani D.; Barugola G.; Mazza L.; Guarini C. (2023). Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group. FRONTIERS IN NUTRITION, vol. 10, pp. 0-0, ISSN:2296-861X DOI

Mariotti, A; Spatafora, P; Sessa, F; Saieva, C; Galli, I C; Roviello, G; Doni, L; Zaccaro, C; Bisegna, C; Conte, F L; Mariottini, R; Marzocco, A; Masieri, L; Vignolini, G; Minervini, A; Serni, S; Carini, M; Nesi, G; Villari, D (2023). Gender and cystectomy for bladder cancer: A high-volume tertiary urologic care center experience. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, vol. 49, pp. 107034-107034, ISSN:0748-7983 DOI

Catalano, Martina; Iannone, Luigi Francesco; Nesi, Gabriella; Nobili, Stefania; Mini, Enrico; Roviello, Giandomenico (2023). Immunotherapy-related biomarkers: Confirmations and uncertainties. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 192, pp. 104135-104136, ISSN:1040-8428 DOI

Catalano, Martina; Lapucci, Andrea; Nobili, Stefania; De Gennaro Aquino, Irene; Vascotto, Ismaela Anna; Antonuzzo, Lorenzo; Villari, Donata; Nesi, Gabriella; Mini, Enrico; Roviello, Giandomenico (2023). Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?. CANCER CHEMOTHERAPY AND PHARMACOLOGY, pp. 0-0, ISSN:0344-5704 DOI

El Zarif, Talal; Nassar, Amin H; Pond, Gregory R; Zhuang, Tony Zibo; Master, Viraj; Nazha, Bassel; Niglio, Scot; Simon, Nicholas; Hahn, Andrew W; Pettaway, Curtis A; Tu, Shi-Ming; Abdel-Wahab, Noha; Velev, Maud; Flippot, Ronan; Buti, Sebastiano; Maruzzo, Marco; Mittra, Arjun; Gheeya, Jinesh; Yang, Yuanquan; Rodriguez, Pablo Alvarez; Castellano, Daniel; de Velasco, Guillermo; Roviello, Giandomenico; Antonuzzo, Lorenzo; McKay, Rana R; Vincenzi, Bruno; Cortellini, Alessio; Hui, Gavin; Drakaki, Alexandra; Glover, Michael; Khaki, Ali Raza; El-Am, Edward; Adra, Nabil; Mouhieddine, Tarek H; Patel, Vaibhav; Piedra, Aida; Gernone, Angela; Davis, Nancy B; Matthews, Harrison; Harrison, Michael R; Kanesvaran, Ravindran; Giudice, Giulia Claire; Barata, Pedro; Farolfi, Alberto; Lee, Jae Lyun; Milowsky, Matthew I; Stahlfeld, Charlotte; Appleman, Leonard; Kim, Joseph W; Freeman, Dory; Choueiri, Toni K; Spiess, Philippe E; Necchi, Andrea; Apolo, Andrea B; Sonpavde, Guru P (2023). Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors. JOURNAL OF THE NATIONAL CANCER INSTITUTE, vol. djad155, pp. 1-10, ISSN:0027-8874 DOI

Catalano, Martina; Lavacchi, Daniele; Giommoni, Elisa; Shabani, Sonia; Guidolin, Alessia; Brugia, Marco; Petrioli, Roberto; Ramello, Monica; Pillozzi, Serena; Antonuzzo, Lorenzo; Roviello, Giandomenico (2023). Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI. FUTURE ONCOLOGY, vol. 19, pp. 2537-2546, ISSN:1479-6694 DOI

Catalano, Martina; Rebuzzi, Sara Elena; Maruzzo, Marco; De Giorgi, Ugo; Buti, Sebastiano; Galli, Luca; Fornarini, Giuseppe; Zucali, Paolo Andrea; Procopio, Giuseppe; Chiellino, Silvia; Milella, Michele; Catalano, Fabio; Pipitone, Stefania; Ricotta, Riccardo; Sorarù, Mariella; Mollica, Veronica; Tudini, Marianna; Fratino, Lucia; Prati, Veronica; Caffo, Orazio; Atzori, Francesco; Morelli, Franco; Prati, Giuseppe; Nolè, Franco; Vignani, Francesca; Cavo, Alessia; Di Napoli, Marilena; Malgeri, Andrea; Naglieri, Emanuele; Signori, Alessio; Banna, Giuseppe Luigi; Rescigno, Pasquale; Antonuzzo, Lorenzo; Roviello, Giandomenico (2023). Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab. JAMA NETWORK OPEN, vol. 6, pp. 1-12, ISSN:2574-3805 DOI

Santoni, Matteo; Massari, Francesco; Myint, Zin W.; Iacovelli, Roberto; Pichler, Martin; Basso, Umberto; Kopecky, Jindrich; Kucharz, Jakub; Buti, Sebastiano; Rizzo, Mimma; Galli, Luca; Büttner, Thomas; De Giorgi, Ugo; Kanesvaran, Ravindran; Fiala, Ondřej; Grande, Enrique; Zucali, Paolo Andrea; Fornarini, Giuseppe; Bourlon, Maria T.; Scagliarini, Sarah; Molina-Cerrillo, Javier; Aurilio, Gaetano; Matrana, Marc R.; Pichler, Renate; Cattrini, Carlo; Büchler, Tomas; Seront, Emmanuel; Calabrò, Fabio; Pinto, Alvaro; Berardi, Rossana; Zgura, Anca; Mammone, Giulia; Ansari, Jawaher; Atzori, Francesco; Chiari, Rita; Bamias, Aristotelis; Caffo, Orazio; Procopio, Giuseppe; Bassanelli, Maria; Merler, Sara; Messina, Carlo; Küronya, Zsófia; Mosca, Alessandra; Bhuva, Dipen; Vau, Nuno; Incorvaia, Lorena; Rebuzzi, Sara Elena; Roviello, Giandomenico; Zabalza, Ignacio Ortego; Rizzo, Alessandro; Mollica, Veronica; Sorgentoni, Giulia; Monteiro, Fernando Sabino M.; Montironi, Rodolfo; Battelli, Nicola; Porta, Camillo (2023). Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study. TARGETED ONCOLOGY, vol. 18, pp. 559-570, ISSN:1776-2596 DOI

Catalano, Martina; Nesi, Gabriella; Roviello, Giandomenico (2023). Tumor microenvironment in renal cell carcinoma: what is the current impact?. FUTURE ONCOLOGY, vol. 19, pp. 1315-1318, ISSN:1479-6694 DOI

Corianò, Matilde; Giannarelli, Diana; Scartabellati, Giulia; De Giorgi, Ugo; Brighi, Nicole; Fornarini, Giuseppe; Tommasi, Chiara; Giudice, Giulia Claire; Rebuzzi, Sara Elena; Puglisi, Silvia; Caffo, Orazio; Kinspergher, Stefania; Mennitto, Alessia; Cattrini, Carlo; Santoni, Matteo; Verzoni, Elena; Rametta, Alessandro; Stellato, Marco; Malgeri, Andrea; Roviello, Giandomenico; Brunelli, Matteo; Signori, Alessio; Banna, Giuseppe Luigi; Buti, Sebastiano (2023). Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?. EXPERT REVIEW OF ANTICANCER THERAPY, vol. -, pp. 1-5, ISSN:1473-7140 DOI

Cosso, Federica; Roviello, Giandomenico; Nesi, Gabriella; Shabani, Sonia; Spatafora, Pietro; Villari, Donata; Catalano, Martina (2023). Adjuvant Therapy for Renal Cell Carcinoma: Hype or Hope?. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 24, pp. 4243-4254, ISSN:1422-0067 DOI

Catalano, Martina; Generali, Daniele; Gatti, Marta; Riboli, Barbara; Paganini, Leda; Nesi, Gabriella; Roviello, Giandomenico (2023). DNA repair deficiency as circulating biomarker in prostate cancer. FRONTIERS IN ONCOLOGY, vol. 13, pp. 1-12, ISSN:2234-943X DOI

Catalano, Martina; Procopio, Giuseppe; Sepe, Pierangela; Santoni, Matteo; Sessa, Francesco; Villari, Donata; Nesi, Gabriella; Roviello, Giandomenico (2023). Tyrosine kinase and immune checkpoints inhibitors in favorable risk metastatic renal cell carcinoma: Trick or treat?. PHARMACOLOGY & THERAPEUTICS, vol. 249, pp. 1-11, ISSN:0163-7258 DOI

Tommasi, Chiara; Scartabellati, Giulia; Giannarelli, Diana; Giorgi, Ugo De; Brighi, Nicole; Fornarini, Giuseppe; Rebuzzi, Sara Elena; Puglisi, Silvia; Caffo, Orazio; Kinspergher, Stefania; Mennitto, Alessia; Cattrini, Carlo; Santoni, Matteo; Verzoni, Elena; Rametta, Alessandro; Stellato, Marco; Malgeri, Andrea; Roviello, Giandomenico; Brunelli, Matteo; Buti, Sebastiano (2023). The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study. THERAPEUTIC ADVANCES IN UROLOGY, vol. 15, pp. 1-24, ISSN:1756-2872 DOI

PORTA, Camillo; BAMIAS, Aristotelis; ZAKOPOULOU, Roubini; MYINT, Zin W.; CAVASIN, Nicolò; IACOVELLI, Roberto; PICHLER, Martin; KOPECKY, Jindrich; KUCHARZ, Jakub; RIZZO, Mimma; GALLI, Luca; BÜTTNER, Thomas; DE GIORGI, Ugo; KANESVARAN, Ravindran; FIALA, Ondřej; GRANDE, Enrique; ZUCALI, Paolo A.; KOPP, Ray M.; FORNARINI, Giuseppe; BOURLON, Maria T.; SCAGLIARINI, Sarah; MOLINA-CERRILLO, Javier; AURILIO, Gaetano; MATRANA, Marc R.; PICHLER, Renate; CATTRINI, Carlo; BÜCHLER, Tomáš; MASSARI, Francesco; MOLLICA, Veronica; SERONT, Emmanuel; CALABRÒ, Fabio; PINTO, Alvaro; BERARDI, Rossana; ZGURA, Anca; MAMMONE, Giulia; ANSARI, Jawaher; ATZORI, Francesco; CHIARI, Rita; CAFFO, Orazio; PROCOPIO, Giuseppe; SUNELA, Kaisa; BASSANELLI, Maria; ORTEGA, Cinzia; GRILLONE, Francesco; LANDMESSER, Johannes; MERLER, Sara; MESSINA, Carlo; KÜRONYA, Zsófia; MOSCA, Alessandra; BHUVA, Dipen; SANTINI, Daniele; VAU, Nuno; MORELLI, Franco; INCORVAIA, Lorena; REBUZZI, Sara E.; ROVIELLO, Giandomenico; SOARES, Andrey; ZABALZA, Ignacio O.; RIZZO, Alessandro; BISONNI, Renato; PIERANTONI, Francesco; SORGENTONI, Giulia; MONTEIRO, Fernando S.; BATTELLI, Nicola; BUTI, Sebastiano; SANTONI, Matteo (2023). Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations. MINERVA UROLOGY AND NEPHROLOGY, vol. 75, pp. 460-470, ISSN:2724-6051 DOI

Fiala, Ondřej; Buti, Sebastiano; Takeshita, Hideki; Okada, Yohei; Massari, Francesco; Palacios, Georgia Anguera; Dionese, Michele; Scagliarini, Sarah; Büttner, Thomas; Fornarini, Giuseppe; Myint, Zin W.; Galli, Luca; Souza, Vinicius Carrera; Pichler, Renate; De Giorgi, Ugo; Quiroga, María Natalia Gandur; Gilbert, Danielle; Popovic, Lazar; Grande, Enrique; Mammone, Giulia; Berardi, Rossana; Crabb, Simon J.; Molina-Cerrillo, Javier; Freitas, Marcelo; Luz, Murilo; Iacovelli, Roberto; Calabrò, Fabio; Tural, Deniz; Atzori, Francesco; Küronya, Zsófia; Chiari, Rita; Campos, Saul; Caffo, Orazio; Fay, André P.; Kucharz, Jakub; Zucali, Paolo Andrea; Rinck, José Augusto; Zeppellini, Annalisa; Bastos, Diogo Assed; Aurilio, Gaetano; Mota, Augusto; Trindade, Karine; Ortega, Cinzia; Sade, Juan Pablo; Rizzo, Mimma; Vau, Nuno; Giannatempo, Patrizia; Barillas, Allan; Monteiro, Fernando Sabino Marques; Dauster, Breno; Cattrini, Carlo; Nogueira, Lucas; de Carvalho Fernandes, Roni; Seront, Emmanuel; Aceituno, Luís Garcia; Grillone, Francesco; Cutuli, Hernan Javier; Fernandez, Mauricio; Bassanelli, Maria; Roviello, Giandomenico; Abahssain, Halima; Procopio, Giuseppe; Milella, Michele; Kopecky, Jindrich; Martignetti, Angelo; Messina, Carlo; Caitano, Manuel; Inman, Eva; Kanesvaran, Ravindran; Herchenhorn, Daniel; Santini, Daniele; Manneh, Ray; Bisonni, Renato; Zakopoulou, Roubini; Mosca, Alessandra; Morelli, Franco; Maluf, Fernando; Soares, Andrey; Nunes, Fernando; Pinto, Alvaro; Zgura, Anca; Incorvaia, Lorena; Ansari, Jawaher; Zabalza, Ignacio Ortego; Landmesser, Johannes; Rizzo, Alessandro; Mollica, Veronica; Sorgentoni, Giulia; Battelli, Nicola; Porta, Camillo; Bellmunt, Joaquim; Santoni, Matteo (2023). Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study. CANCER IMMUNOLOGY, IMMUNOTHERAPY, vol. 72, pp. 3665-3682, ISSN:0340-7004 DOI

Mazzaschi, Giulia; Lazzarin, Alessandro; Santoni, Matteo; Trentini, Francesca; Giorgi, Ugo De; Brighi, Nicole; Tommasi, Chiara; Puglisi, Silvia; Caffo, Orazio; Kinspergher, Stefania; Mennitto, Alessia; Cattrini, Carlo; Verzoni, Elena; Rametta, Alessandro; Stellato, Marco; Malgeri, Andrea; Roviello, Giandomenico; Silini, Enrico Maria; Rescigno, Pasquale; Rebuzzi, Sara Elena; Fornarini, Giuseppe; Quaini, Federico; Giudice, Giulia Claire; Banna, Giuseppe Luigi; Buti, Sebastiano (2023). Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score. FRONTIERS IN BIOSCIENCE, vol. 15, pp. 1-11, ISSN:1945-0494 DOI

Catalano, Martina; Roviello, Giandomenico; Aprile, Giuseppe; Ramello, Monica; Conca, Raffaele; Petrioli, Roberto; Perrone, Gabriele; Ianza, Anna; Mini, Enrico (2023). Prognostic value of alkaline phosphatase and gamma-glutamyl transferase in patients with metastatic pancreatic cancer. FUTURE ONCOLOGY, vol. 19, pp. 937-946, ISSN:1479-6694 DOI

Bersanelli, Melissa; Rebuzzi, Sara Elena; Roviello, Giandomenico; Catalano, Martina; Brunelli, Matteo; Rizzo, Mimma (2023). Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma. HUMAN VACCINES & IMMUNOTHERAPEUTICS, vol. 19, pp. 1-11, ISSN:2164-5515 DOI

Sobhani, Navid; Mondani, Giuseppina; Roviello, Giandomenico; Catalano, Martina; Sirico, Marianna; D’Angelo, Alberto; Scaggiante, Bruna; Generali, Daniele (2023). Cancer management during the COVID-19 world pandemic. CANCER IMMUNOLOGY, IMMUNOTHERAPY, vol. 72, pp. 3427-3444, ISSN:0340-7004 DOI

Maiorano, Brigida Anna; Conteduca, Vincenza; Catalano, Martina; Antonuzzo, Lorenzo; Maiello, Evaristo; De Giorgi, Ugo; Roviello, Giandomenico (2023). Personalized medicine for metastatic prostate cancer: The paradigm of PARP inhibitors. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 192, pp. 1-13, ISSN:1040-8428 DOI

Catalano, Martina; Roviello, Giandomenico; Santi, Raffaella; Villari, Donata; Spatafora, Pietro; Galli, Ilaria Camilla; Sessa, Francesco; Conte, Francesco Lupo; Mini, Enrico; Cai, Tommaso; Nesi, Gabriella (2023). Inflammation in Urological Malignancies: The Silent Killer. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 24, pp. 866-866, ISSN:1422-0067 DOI

Sforza, Simone; Palmieri, Valeria Emma; Raspollini, Maria Rosaria; Roviello, Giandomenico; Mantovani, Alberto; Basso, Umberto; Affinita, Maria Carmen; D'Angelo, Alberto; Antonuzzo, Lorenzo; Carini, Marco; Minervini, Andrea; Masieri, Lorenzo (2023). Robotic approach with neoadjuvant chemotherapy in adult Wilms' tumor: A feasibility study report and a systematic review of the literature. ASIAN JOURNAL OF UROLOGY, vol. 10, pp. 128-136, ISSN:2214-3882 DOI

Lavacchi, Daniele; Roviello, Giandomenico; Guidolin, Alessia; Romano, Silvia; Venturini, Jacopo; Caliman, Enrico; Vannini, Agnese; Giommoni, Elisa; Pellegrini, Elisa; Brugia, Marco; Pillozzi, Serena; Antonuzzo, Lorenzo (2023). Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 24, pp. 5840-5851, ISSN:1422-0067 DOI

Santoni, Matteo; Massari, Francesco; Myint, Zin W; Iacovelli, Roberto; Pichler, Martin; Basso, Umberto; Kopecky, Jindrich; Kucharz, Jakub; Buti, Sebastiano; Salfi, Alessia; Büttner, Thomas; De Giorgi, Ugo; Kanesvaran, Ravindran; Fiala, Ondřej; Grande, Enrique; Zucali, Paolo Andrea; Fornarini, Giuseppe; Bourlon, Maria T; Scagliarini, Sarah; Molina-Cerrillo, Javier; Aurilio, Gaetano; Matrana, Marc R; Pichler, Renate; Cattrini, Carlo; Büchler, Tomas; Seront, Emmanuel; Calabrò, Fabio; Pinto, Alvaro; Berardi, Rossana; Zgura, Anca; Mammone, Giulia; Ansari, Jawaher; Atzori, Francesco; Chiari, Rita; Zakopoulou, Roubini; Caffo, Orazio; Procopio, Giuseppe; Bassanelli, Maria; Zampiva, Ilaria; Messina, Carlo; Küronya, Zsófia; Mosca, Alessandra; Bhuva, Dipen; Vau, Nuno; Incorvaia, Lorena; Rebuzzi, Sara Elena; Roviello, Giandomenico; Zabalza, Ignacio Ortego; Rizzo, Alessandro; Mollica, Veronica; Catalini, Ilaria; Monteiro, Fernando Sabino M; Montironi, Rodolfo; Battelli, Nicola; Rizzo, Mimma; Porta, Camillo (2023). Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1). CLINICAL GENITOURINARY CANCER, pp. 1-12, ISSN:1938-0682 DOI

Cosso, Federica; Roviello, Giandomenico; Catalano, Martina; Botteri, Cristina; Comin, Camilla Eva; Castiglione, Francesca; Ferrari, Katia; Baldini, Editta; Mini, Enrico (2023). A case report of a lung cancer patient with two uncommon EGFR mutations and a review of the literature: two sides of the same coin. ANTI-CANCER DRUGS, vol. Publish Ahead of Print, pp. 1-6, ISSN:0959-4973 DOI

Buti, Sebastiano; Tommasi, Chiara; Scartabellati, Giulia; De Giorgi, Ugo; Brighi, Nicole; Rebuzzi, Sara Elena; Puglisi, Silvia; Caffo, Orazio; Kinspergher, Stefania; Mennitto, Alessia; Cattrini, Carlo; Santoni, Matteo; Verzoni, Elena; Rametta, Alessandro; Stellato, Marco; Malgeri, Andrea; Roviello, Giandomenico; de Filippo, Massimo; Cortellini, Alessio; Bersanelli, Melissa (2023). The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma. ANTI-CANCER DRUGS, vol. 34, pp. 178-186, ISSN:1473-5741 DOI Accesso ONLINE all'editore

Roviello, Giandomenico; Catalano, Martina; Ottanelli, Carlotta; Giorgione, Roberta; Rossi, Virginia; Gambale, Elisabetta; Casadei, Chiara; De Giorgi, Ugo; Antonuzzo, Lorenzo (2022). Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice. MEDICAL ONCOLOGY, vol. 39, pp. 0-0, ISSN:1357-0560 DOI Accesso ONLINE all'editore

D'Angelo, Alberto; Chapman, Robert; Sirico, Marianna; Sobhani, Navid; Catalano, Martina; Mini, Enrico; Roviello, Giandomenico (2022). An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes next. CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol. 90, pp. 191-205, ISSN:0344-5704 DOI

Lavacchi, Daniele; Fancelli, Sara; Roviello, Giandomenico; Castiglione, Francesca; Caliman, Enrico; Rossi, Gemma; Venturini, Jacopo; Pellegrini, Elisa; Brugia, Marco; Vannini, Agnese; Bartoli, Caterina; Cianchi, Fabio; Pillozzi, Serena; Antonuzzo, Lorenzo (2022). Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer. FRONTIERS IN ONCOLOGY, vol. 12, pp. 1055019-1055030, ISSN:2234-943X DOI Accesso ONLINE all'editore

Roviello, G; Catalano, M; Iannone, L F; Marano, L; Brugia, M; Rossi, G; Aprile, G; Antonuzzo, L (2022). Current status and future perspectives in HER2 positive advanced gastric cancer. CLINICAL & TRANSLATIONAL ONCOLOGY, vol. 24, pp. 981-996, ISSN:1699-048X DOI Accesso ONLINE all'editore

Roviello, Giandomenico; Catalano, Martina; De Giorgi, Ugo; Maruzzo, Marco; Buti, Sebastiano; Gambale, Elisabetta; Procopio, Giuseppe; Ottanelli, Carlotta; Caliman, Enrico; Isella, Luca; Sepe, Pierangela; Brighi, Nicole; Santoni, Matteo; Galli, Luca; Conca, Raffaele; Doni, Laura; Antonuzzo, Lorenzo (2022). Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors. FRONTIERS IN ONCOLOGY, vol. 12, pp. 1-14, ISSN:2234-943X DOI Accesso ONLINE all'editore

Sobhani, Navid; Scaggiante, Bruna; Morris, Rachel; Chai, Dafei; Catalano, Martina; Tardiel-Cyril, Dana Rae; Neeli, Praveen; Roviello, Giandomenico; Mondani, Giuseppina; Li, Yong (2022). Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials. CANCER TREATMENT REVIEWS, vol. 109, pp. 102429-102445, ISSN:0305-7372 DOI Accesso ONLINE all'editore

Xie, Yuanzhi; Mirzaei, Mina; Kahrizi, Mohammad Saeed; Shabestari, Alireza Mohammadzade; Riahi, Seyed Mohammad; Farsimadan, Marziye; Roviello, Giandomenico (2022). SARS-CoV-2 effects on sperm parameters: a meta-analysis study. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, vol. 39, pp. 1555-1563, ISSN:1058-0468 DOI Accesso ONLINE all'editore

Di Lorenzo, Giuseppe; Iervolino, Mario; Primiano, Ferdinando; D'Ambrosio, Maurizio; Ingenito, Concetta; Buonerba, Luciana; Busto, Giuseppina; Ferrara, Claudia; Libroia, Annamaria; Ragone, Gianluca; De Falco, Ferdinando; Costabile, Ferdinando; Fimiani, Pietro; Ugliano, Francesco; Ranieri, Chiara; Leo, Emilio; Roviello, Giandomenico; Scafuri, Luca; Guerra, Germano; Buonerba, Carlo (2022). The Impact of Routine Molecular Screening for SARS-CoV-2 in Patients Receiving Anticancer Therapy: An Interim Analysis of the Observational COICA Study. ONCOLOGY, vol. 100, pp. 505-511, ISSN:0030-2414 DOI Accesso ONLINE all'editore

Maiorano, B A; De Giorgi, U; Roviello, G; Messina, C; Altavilla, A; Cattrini, C; Mennitto, A; Maiello, E; Di Maio, M (2022). Addition of androgen receptor-targeted agents to androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis. ESMO OPEN, vol. 7, pp. 1-9, ISSN:2059-7029 DOI Accesso ONLINE all'editore

Catalano, Martina; Shabani, Sonia; Venturini, Jacopo; Ottanelli, Carlotta; Voltolini, Luca; Roviello, Giandomenico (2022). Lung Cancer Immunotherapy: Beyond Common Immune Checkpoints Inhibitors. CANCERS, vol. 14, pp. 1-26, ISSN:2072-6694 DOI Accesso ONLINE all'editore

Roviello, Giandomenico; Aprile, Giuseppe; Catalano, Martina; Ramello, Monica; Conca, Raffaele; Petrioli, Roberto (2022). Capecitabine as a Second-line Treatment for Older Patients with Pancreatic Cancer. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, vol. 23, pp. 1788-1791, ISSN:1389-2010 DOI

Roviello, Giandomenico; Bersanelli, Melissa; Catalano, Martina (2022). The latest developments in biomarkers predicting response to immunotherapy. IMMUNOTHERAPY, vol. 14, pp. 1085-1088, ISSN:1750-743X DOI

Catalano, Martina; Roviello, Giandomenico; Galli, Ilaria Camilla; Santi, Raffaella; Nesi, Gabriella (2022). Immune checkpoint inhibitor induced nephrotoxicity: An ongoing challenge. FRONTIERS IN MEDICINE, vol. 9, pp. 1014257-1014267, ISSN:2296-858X DOI Accesso ONLINE all'editore

Rebuzzi, Sara Elena; Signori, Alessio; Stellato, Marco; Santini, Daniele; Maruzzo, Marco; De Giorgi, Ugo; Pedrazzoli, Paolo; Galli, Luca; Zucali, Paolo Andrea; Fantinel, Emanuela; Carella, Claudia; Procopio, Giuseppe; Milella, Michele; Boccardo, Francesco; Fratino, Lucia; Sabbatini, Roberto; Ricotta, Riccardo; Panni, Stefano; Massari, Francesco; Sorarù, Mariella; Santoni, Matteo; Cortellini, Alessio; Prati, Veronica; Soto Parra, Hector Josè; Atzori, Francesco; Di Napoli, Marilena; Caffo, Orazio; Messina, Marco; Morelli, Franco; Prati, Giuseppe; Nolè, Franco; Vignani, Francesca; Cavo, Alessia; Roviello, Giandomenico; Llaja Obispo, Miguel Angel; Porta, Camillo; Buti, Sebastiano; Fornarini, Giuseppe; Banna, Giuseppe Luigi (2022). The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis. FRONTIERS IN ONCOLOGY, vol. 12, pp. 955501-955515, ISSN:2234-943X DOI Accesso ONLINE all'editore

Passarelli, Anna; Galdo, Giovanna; Pellegrino, Teresa; Roviello, Giandomenico; Aieta, Michele; Aviello, Gabriella; Conca, Raffaele (2022). Therapeutic management of a symptomatic Kaposi's sarcoma patient with renal failure undergoing haemodialysis: A case report. DERMATOLOGY REPORTS, vol. 14, pp. 9113-9116, ISSN:2036-7392 DOI Accesso ONLINE all'editore

Di Lorenzo, Giuseppe; Ingenito, Concetta; D'Ambrosio, Bruno; Ranieri, Chiara; Iuliucci, Michela Rosaria; Iervolino, Mario; Primiano, Ferdinando; Buonerba, Luciana; Busto, Giuseppina; Ferrara, Claudia; Libroia, Annamaria; Ragone, Gianluca; De Falco, Ferdinando; Costabile, Ferdinando; Fimiani, Pietro; Ugliano, Francesco; Leo, Emilio; Roviello, Giandomenico; Scafuri, Luca; Buonerba, Carlo (2022). The Effect of Vaccination against COVID-19 in Cancer Patients: Final Results of the COICA Trial. ONCOLOGY, vol. 100, pp. 512-518, ISSN:0030-2414 DOI Accesso ONLINE all'editore

Catalano, Martina; Ramello, Monica; Conca, Raffaele; Aprile, Giuseppe; Petrioli, Roberto; Roviello, Giandomenico (2022). Risk Factors for Nab-Paclitaxel and Gemcitabine-Induced Peripheral Neuropathy in Patients with Pancreatic Cancer. ONCOLOGY, vol. 100, pp. 384-391, ISSN:0030-2414 DOI Accesso ONLINE all'editore

Roviello, Giandomenico; Catalano, Martina (2022). Editorial: Microbiota and metabolites in cancer immunotherapy. FRONTIERS IN ONCOLOGY, vol. 12, pp. 1093941-1093944, ISSN:2234-943X DOI Accesso ONLINE all'editore

Catalano, Martina; Aprile, Giuseppe; Conca, Raffaele; Petrioli, Roberto; Ramello, Monica; Roviello, Giandomenico (2022). The impact of age, performance status and comorbidities on nab-paclitaxel plus gemcitabine effectiveness in patients with metastatic pancreatic cancer. SCIENTIFIC REPORTS, vol. 12, pp. 8244-8250, ISSN:2045-2322 DOI Accesso ONLINE all'editore

Zhang, Kaiping; Tartarone, Alfredo; Pérez-Ríos, Mónica; Novello, Silvia; Mariniello, Annapaola; Roviello, Giandomenico; Zhang, Jianrong (2022). Smoking burden, MPOWER, future tobacco control and real-world challenges in China: reflections on the WHO report on the global tobacco epidemic 2021. TRANSLATIONAL LUNG CANCER RESEARCH, vol. 11, pp. 117-121, ISSN:2218-6751 DOI

Catalano, Martina; Francesco Iannone, Luigi; Cosso, Federica; Generali, Daniele; Mini, Enrico; Roviello, Giandomenico (2022). Combining inhibition of immune checkpoints and PARP: rationale and perspectives in cancer treatment. EXPERT OPINION ON THERAPEUTIC TARGETS, pp. 1-14, ISSN:1472-8222 DOI

Mazurek, Marek; Szlendak, Małgorzata; Forma, Alicja; Baj, Jacek; Maciejewski, Ryszard; Roviello, Giandomenico; Marano, Luigi; Roviello, Franco; Polom, Karol; Sitarz, Robert (2022). Hyperthermic Intraperitoneal Chemotherapy in the Management of Gastric Cancer: A Narrative Review. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, vol. 19, pp. 681-699, ISSN:1660-4601 DOI Accesso ONLINE all'editore

Cwalinski, Tomasz; Skokowski, Jarosław; Polom, Wojciech; Marano, Luigi; Swierblewski, Maciej; Drucis, Kamil; Roviello, Giandomenico; Cwalina, Natalia; Kalinowski, Leszek; Roviello, Franco; Polom, Karol (2022). Fluorescence Imaging Using Methylene Blue Sentinel Lymph Node Biopsy in Melanoma. SURGICAL INNOVATION, vol. 29, pp. 503-510, ISSN:1553-3506 DOI Accesso ONLINE all'editore

Raggi, Daniele; Giannatempo, Patrizia; Marandino, Laura; Pierantoni, Francesco; Maruzzo, Marco; Lipari, Helga; Banna, Giuseppe L; De Giorgi, Ugo; Casadei, Chiara; Naglieri, Emanuele; Buti, Sebastiano; Bersanelli, Melissa; Stellato, Marco; Santini, Daniele; Vignani, Francesca; Roviello, Giandomenico; Veccia, Antonello; Caffo, Orazio; Losanno, Tania; Calabrò, Fabrizio; Mucciarini, Claudia; Pignata, Sandro; Necchi, Andrea; Maio, Massimo Di (2022). Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study. CLINICAL GENITOURINARY CANCER, vol. 20, pp. 155-164, ISSN:1558-7673 DOI Accesso ONLINE all'editore

Roviello, Giandomenico; Nardone, Valerio; Bonetta, Alberto; Correale, Pierpaolo; Molteni, Alfredo; Lazzari, Maria C; Generali, Daniele (2022). Effects of Whole Pelvic Radiotherapy on the Distribution of Lymphocyte Subpopulations in Prostate Cancer Patients. AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS, vol. 45, pp. 105-111, ISSN:0277-3732 DOI Accesso ONLINE all'editore

Lavacchi, Daniele; Caliman, Enrico; Rossi, Gemma; Buttitta, Eleonora; Botteri, Cristina; Fancelli, Sara; Pellegrini, Elisa; Roviello, Giandomenico; Pillozzi, Serena; Antonuzzo, Lorenzo (2022). Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions. PHARMACOLOGY & THERAPEUTICS, vol. 237, pp. 108170-108170, ISSN:0163-7258 DOI

Roviello, Giandomenico; Lavacchi, Daniele; Antonuzzo, Lorenzo; Catalano, Martina; Mini, Enrico (2022). Liquid biopsy in colorectal cancer: No longer young, but not yet old. WORLD JOURNAL OF GASTROENTEROLOGY, vol. 28, pp. 1503-1507, ISSN:2219-2840 DOI

Roviello, Giandomenico; Gambale, Elisabetta; Giorgione, Roberta; Santini, Daniele; Stellato, Marco; Fornarini, Giuseppe; Rebuzzi, Sara Elena; Basso, Umberto; Bimbatti, Davide; Doni, Laura; Nesi, Gabriella; Bersanelli, Melissa; Buti, Sebastiano; De Giorgi, Ugo; Galli, Luca; Sbrana, Andrea; Conca, Raffaele; Carella, Claudia; Naglieri, Emanuele; Pignata, Sandro; Procopio, Giuseppe; Antonuzzo, Lorenzo (2022). Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet-Uro 19BEYOND study. CANCER MEDICINE, vol. 11, pp. 3084-3092, ISSN:2045-7634 DOI

Nozzoli, Filippo; Lazar, Alexander J; Castiglione, Francesca; Campanacci, Domenico Andrea; Beltrami, Giovanni; De Logu, Francesco; Caporalini, Chiara; Massi, Daniela; Roviello, Giandomenico (2022). NTRK Fusions Detection in Paediatric Sarcomas to Expand the Morphological Spectrum and Clinical Relevance of Selected Entities. PATHOLOGY AND ONCOLOGY RESEARCH, vol. 28, pp. 0-0, ISSN:1532-2807 DOI

Boccaccino, A; Borelli, B; Intini, R; Antista, M; Bensi, M; Rossini, D; Passardi, A; Tamberi, S; Giampieri, R; Antonuzzo, L; Noto, L; Roviello, G; Zichi, C; Salati, M; Puccini, A; Noto, C; Parisi, A; Rihawi, K; Persano, M; Crespi, V; Libertini, M; Giordano, M; Moretto, R; Lonardi, S; Cremolini, C (2022). Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience. ESMO OPEN, vol. 7, pp. 1-8, ISSN:2059-7029 DOI

Palmieri, Valeria Emma; Roviello, Giandomenico; Catalano, Martina; D'Angelo, Alberto; Vannini, Gianmarco; Buttitta, Eleonora; Mini, Enrico (2022). Immune checkpoint inhibitor-induced neurologic toxicity: a case report and literature review. IMMUNOTHERAPY, vol. 14, pp. 505-510, ISSN:1750-743X DOI

Rebuzzi, Sara Elena; Signori, Alessio; Banna, Giuseppe Luigi; Gandini, Annalice; Fornarini, Giuseppe; Damassi, Alessandra; Maruzzo, Marco; De Giorgi, Ugo; Basso, Umberto; Chiellino, Silvia; Galli, Luca; Zucali, Paolo Andrea; Fantinel, Emanuela; Naglieri, Emanuele; Procopio, Giuseppe; Milella, Michele; Boccardo, Francesco; Fratino, Lucia; Pipitone, Stefania; Ricotta, Riccardo; Panni, Stefano; Mollica, Veronica; Sorarù, Mariella; Santoni, Matteo; Cortellini, Alessio; Prati, Veronica; Soto Parra, Hector Josè; Santini, Daniele; Atzori, Francesco; Di Napoli, Marilena; Caffo, Orazio; Messina, Marco; Morelli, Franco; Prati, Giuseppe; Nolè, Franco; Vignani, Francesca; Cavo, Alessia; Roviello, Giandomenico; Rescigno, Pasquale; Buti, Sebastiano (2022). The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study. JOURNAL OF TRANSLATIONAL MEDICINE, vol. 20, pp. 435-441, ISSN:1479-5876 DOI Accesso ONLINE all'editore

Roviello, Giandomenico; Martina, Catalano; Winchler, Costanza; De Gennaro Aquino, Irene; Papa, Francesca; Buttitta, Eleonora; Rossi, Gemma; Antonuzzo, Lorenzo (2022). Correlation Between Tumor Response and Survival Outcomes in Patients with Advanced Gastric Cancer Receiving Ramucirumab and Paclitaxel as Second-Line Therapy. JOURNAL OF GASTROINTESTINAL CANCER, pp. 0-0, ISSN:1941-6628 DOI Accesso ONLINE all'editore

Fancelli, S; Roviello, G; Castiglione, F; Caliman, E; Mazzoni F, null; Paglialunga L, null; Pillozzi, S; Antonuzzo, L (2022). Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, vol. 23, pp. 0-0, ISSN:1389-2010 DOI Accesso ONLINE all'editore

Catalano M.; Marini A.; Ferrari K.; Voltolini L.; Cianchi F.; Comin C.E.; Castiglione F.; Roviello G.; Mini E. (2022). Gastric and colonic metastasis from NSCLC A very unusual case report. MEDICINE, vol. 101, pp. E28249-E28249, ISSN:0025-7974 DOI

Roviello G.; Iannone L.F.; Bersanelli M.; Mini E.; Catalano M. (2022). The gut microbiome and efficacy of cancer immunotherapy. PHARMACOLOGY & THERAPEUTICS, vol. 231, pp. 107973-107983, ISSN:0163-7258 DOI

Catalano, Martina; De Giorgi, Ugo; Maruzzo, Marco; Bimbatti, Davide; Buti, Sebastiano; Mazzaschi, Giulia; Procopio, Giuseppe; Santoni, Matteo; Galli, Luca; Conca, Raffaele; Doni, Laura; Antonuzzo, Lorenzo; Roviello, Giandomenico (2022). Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma. BIOMEDICINES, vol. 10, pp. 1-12, ISSN:2227-9059 DOI Accesso ONLINE all'editore

Antonuzzo, Lorenzo; Caliman, Enrico; Petrella, Maria Cristina; Rossi, Virginia; Mazzoni, Francesca; Grosso, Anna Maria; Fancelli, Sara; Paglialunga, Luca; Comin, Camilla; Roviello, Giandomenico; Pillozzi, Serena (2022). Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer. CURRENT CANCER DRUG TARGETS, vol. 22, pp. 0-0, ISSN:1568-0096 DOI

Roviello, Giandomenico; Catalano, Martina; Santi, Raffaella; Santoni, Matteo; Galli, Ilaria Camilla; Amorosi, Andrea; Polom, Wojciech; De Giorgi, Ugo; Nesi, Gabriella (2022). Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments. FRONTIERS IN ONCOLOGY, vol. 12, pp. 0-0, ISSN:2234-943X DOI

Roudi, Raheleh; Beikzadeh, Behnaz; Roviello, Giandomenico; D'angelo, Alberto; Hadizadeh, Morteza (2022). Identification of hub genes, modules and biological pathways associated with lung adenocarcinoma: A system biology approach. GENE REPORTS, vol. 27, pp. 1-11, ISSN:2452-0144 DOI

Roviello, Giandomenico; Spatafora, Pietro; Sessa, Francesco; Bisegna, Claudio; Catalano, Martina; Liaci, Andrea; Verdelli, Lorenzo; Illiano, Ester; Galli, Ilaria Camilla; Detti, Beatrice; Nesi, Gabriella; Vignolini, Graziano; Villari, Donata (2022). Antiangiogenic drugs as chemosensitizer in renal cell cancer. In: Lucia Morbidelli. Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy: volume 18, pp. 79-84 Elsevier, ISBN:9780323901901., vol. 18: DOI

Sessa, Francesco; Spatafora, Pietro; Roviello, Giandomenico; Bisegna, Claudio; Catalano, Martina; Liaci, Andrea; Verdelli, Lorenzo; Illiano, Ester; Galli, Ilaria Camilla; Detti, Beatrice; Nesi, Gabriella; Vignolini, Graziano; Villari, Donata (2022). Antiangiogenic drugs as chemosensitizer in genitourinary cancer. In: Lucia Morbidelli. Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy: volume 18, pp. 85-92 Elsevier, ISBN:9780323901901., vol. 18: DOI

Mennitto, Alessia; Zattarin, Emma; Di Maio, Massimo; Bimbatti, Davide; De Giorgi, Ugo; Buti, Sebastiano; Santini, Daniele; Casadei, Chiara; Sorarù, Mariella; Messina, Carlo; Mucciarini, Claudia; Di Lorenzo, Giuseppe; Roviello, Giandomenico; Buttigliero, Consuelo; Stellato, Marco; Sepe, Pierangela; Claps, Melanie; Guadalupi, Valentina; Ottini, Arianna; Pignata, Sandro; De Braud, Filippo G; Verzoni, Elena; Procopio, Giuseppe (2022). Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21). EXPERT REVIEW OF ANTICANCER THERAPY, vol. 22, pp. 115-121, ISSN:1473-7140 DOI Accesso ONLINE all'editore

Catalano, Martina; Nesi, Gabriella; Roviello, Giandomenico (2022). Immune combinations and complete response: a new hope for metastatic renal cell carcinoma. REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, vol. 27, pp. 1123-1124, ISSN:1507-1367 DOI

Becattini, Lucrezia; Saieva, Calogero; Doni, Laura; Roviello, Giandomenico; Spatafora, Pietro; Catalano, Martina; Sessa, Francesco; Galli, Ilaria Camilla; Bisegna, Claudio; Conte, Francesco Lupo; Zaccaro, Claudia; Santi, Raffaella; Serni, Sergio; Nesi, Gabriella; Villari, Donata (2022). Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy. MEDICINA, vol. 58, pp. 886-896, ISSN:1010-660X DOI Accesso ONLINE all'editore

Lavacchi D.; Landini I.; Perrone G.; Roviello G.; Mini E.; Nobili S. (2022). Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge. PHARMACOLOGY & THERAPEUTICS, vol. 229, pp. 1-16, ISSN:0163-7258 DOI Accesso ONLINE all'editore

Kaźmierczak-Siedlecka, Karolina; Daca, Agnieszka; Roviello, Giandomenico; Catalano, Martina; Połom, Karol (2022). Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis-what is currently known?. GASTRIC CANCER, vol. 25, pp. 1-10, ISSN:1436-3291 DOI Accesso ONLINE all'editore

Rebuzzi, Sara Elena; Signori, Alessio; Banna, Giuseppe Luigi; Maruzzo, Marco; De Giorgi, Ugo; Pedrazzoli, Paolo; Sbrana, Andrea; Zucali, Paolo Andrea; Masini, Cristina; Naglieri, Emanuele; Procopio, Giuseppe; Merler, Sara; Tomasello, Laura; Fratino, Lucia; Baldessari, Cinzia; Ricotta, Riccardo; Panni, Stefano; Mollica, Veronica; Sorarù, Maria; Santoni, Matteo; Cortellini, Alessio; Prati, Veronica; Soto Parra, Hector Josè; Stellato, Marco; Atzori, Francesco; Pignata, Sandro; Messina, Carlo; Messina, Marco; Morelli, Franco; Prati, Giuseppe; Nolè, Franco; Vignani, Francesca; Cavo, Alessia; Roviello, Giandomenico; Pierantoni, Francesco; Casadei, Chiara; Bersanelli, Melissa; Chiellino, Silvia; Paolieri, Federico; Perrino, Matteo; Brunelli, Matteo; Iacovelli, Roberto; Porta, Camillo; Buti, Sebastiano; Fornarini, Giuseppe (2021). Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study). THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, vol. 13, pp. 17588359211019642-17588359211019654, ISSN:1758-8340 DOI Accesso ONLINE all'editore

Lapucci, Andrea; Perrone, Gabriele; Di Paolo, Antonello; Napoli, Cristina; Landini, Ida; Roviello, Giandomenico; Calosi, Laura; Naccarato, Antonio Giuseppe; Falcone, Alfredo; Bani, Daniele; Mini, Enrico; Nobili, Stefania (2021). PNN and KCNQ1OT1 can predict the efficacy of adjuvant fluoropyrimidine-based chemotherapy in colorectal cancer patients. ONCOLOGY RESEARCH, vol. 28, pp. 631-644, ISSN:0965-0407 DOI

Petrelli, Fausto; Ferrara, Roberto; Signorelli, Diego; Ghidini, Antonio; Proto, Claudia; Roudi, Raheleh; Sabet, Mehrdad N; Facelli, Sara; Garassino, Marina C; Luciani, Andrea; Roviello, Giandomenico (2021). Immune checkpoint inhibitors and chemotherapy in first-line NSCLC: a meta-analysis. IMMUNOTHERAPY, vol. 13, pp. 621-631, ISSN:1750-743X DOI Accesso ONLINE all'editore

von Eyben, Finn E; Kairemo, Kalevi; Paller, Channing; Hoffmann, Manuela Andrea; Paganelli, Giovanni; Virgolini, Irene; Roviello, Giandomenico (2021). 177Lu-PSMA Radioligand Therapy Is Favorable as Third-Line Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. BIOMEDICINES, vol. 9, pp. 1042-1059, ISSN:2227-9059 DOI Accesso ONLINE all'editore

Roviello, Giandomenico; Catalano, Martina; D'Angelo, Alberto; Palmieri, Valeria Emma (2021). Second line of treatment for HER2-positive gastric cancer: an evolving issue. REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, vol. 26, pp. 316-317, ISSN:1507-1367 DOI Accesso ONLINE all'editore

Ianza, Anna; Di Chicco, A; Biagi, C; Giudici, F; Dicorato, A; Guglielmi, A; Variola, F; Tomasi, S; Roviello, G; Generali, D; Zanconati, F (2021). EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol. 147, pp. 2301-2307, ISSN:0171-5216 DOI Accesso ONLINE all'editore

Palmieri, Valeria Emma; Roviello, Giandomenico; D'Angelo, Alberto; Casadei, Chiara; De Giorgi, Ugo; Giorgione, Roberta (2021). Darolutamide in hormone-sensitive and castration-resistant prostate cancer. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, vol. 14, pp. 535-544, ISSN:1751-2433 DOI Accesso ONLINE all'editore

Sturchio, Andrea; Dwivedi, Alok K; Vizcarra, Joaquin A; Chirra, Martina; Keeling, Elizabeth G; Mata, Ignacio F; Kauffman, Marcelo A; Pandey, Manoj K; Roviello, Giandomenico; Comi, Cristoforo; Versino, Maurizio; Marsili, Luca; Espay, Alberto J (2021). Genetic parkinsonisms and cancer: a systematic review and meta-analysis. REVIEWS IN THE NEUROSCIENCES, vol. 32, pp. 159-167, ISSN:0334-1763 DOI Accesso ONLINE all'editore

Roviello, Giandomenico; Buti, Sebastiano; Cattrini, Carlo; Mennitto, Alessia; Messina, Carlo; Airoldi, Chiara; Vannini, Gianmarco; Bersanelli, Melissa (2021). Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?. THERAPEUTIC ADVANCES IN UROLOGY, vol. 13, pp. 17562872211029784-17562872211029785, ISSN:1756-2872 DOI Accesso ONLINE all'editore

Kaźmierczak-Siedlecka, Karolina; Roviello, Giandomenico; Catalano, Martina; Polom, Karol (2021). Gut Microbiota Modulation in the Context of Immune-Related Aspects of Lactobacillus spp. and Bifidobacterium spp. in Gastrointestinal Cancers. NUTRIENTS, vol. 13, pp. 2674-2686, ISSN:2072-6643 DOI Accesso ONLINE all'editore

Roviello, Giandomenico; D'Angelo, Alberto; Sirico, Marianna; Pittacolo, Matteo; Conter, Felipe Umpierre; Sobhani, Navid (2021). Advances in anti-BRAF therapies for lung cancer. INVESTIGATIONAL NEW DRUGS, vol. 39, pp. 879-890, ISSN:0167-6997 DOI Accesso ONLINE all'editore

Kaźmierczak-Siedlecka, Karolina; Skonieczna-Żydecka, Karolina; Biliński, Jarosław; Roviello, Giandomenico; Iannone, Luigi Francesco; Atzeni, Alessandro; Sobocki, Bartosz Kamil; Połom, Karol (2021). Gut Microbiome Modulation and Faecal Microbiota Transplantation Following Allogenic Hematopoietic Stem Cell Transplantation. CANCERS, vol. 13, pp. 4665-4683, ISSN:2072-6694 DOI Accesso ONLINE all'editore

Stellato, Marco; Procopio, Giuseppe; De Giorgi, Ugo; Maruzzo, Marco; Bimbatti, Davide; Mennitto, Alessia; Sbrana, Andrea; Roviello, Giandomenico; Casadei, Chiara; Sepe, Pierangela; Pignata, Sandro; Santini, Daniele (2021). Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators. JOURNAL OF TRANSLATIONAL MEDICINE, vol. 19, pp. 328-335, ISSN:1479-5876 DOI Accesso ONLINE all'editore

Catalano, Martina; Aprile, Giuseppe; Ramello, Monica; Conca, Raffaele; Petrioli, Roberto; Roviello, Giandomenico (2021). Association between Low-Grade Chemotherapy-Induced Peripheral Neuropathy (CINP) and Survival in Patients with Metastatic Adenocarcinoma of the Pancreas. JOURNAL OF CLINICAL MEDICINE, vol. 10, pp. 1846-1856, ISSN:2077-0383 DOI Accesso ONLINE all'editore

Inno, Alessandro; Roviello, Giandomenico; Ghidini, Antonio; Luciani, Andrea; Catalano, Martina; Gori, Stefania; Petrelli, Fausto (2021). Rechallenge of immune checkpoint inhibitors: A systematic review and meta-analysis. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 165, pp. 103434-103441, ISSN:1040-8428 DOI Accesso ONLINE all'editore

Sobhani, Navid; Roviello, Giandomenico; D'Angelo, Alberto; Roudi, Raheleh; Neeli, Praveen Kumar; Generali, Daniele (2021). p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis. MOLECULES, vol. 26, pp. 6215-6224, ISSN:1420-3049 DOI Accesso ONLINE all'editore

Bernocchi, Ottavia; Sirico, Marianna; Corona, Silvia Paola; Strina, Carla; Milani, Manuela; Cappelletti, Maria Rosa; Ferrero, Giuseppina; Ziglioli, Nicoletta; Cervoni, Valeria; Macchiavelli, Andrea; Roviello, Giandomenico; Generali, Daniele (2021). Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature. PHARMACEUTICALS, vol. 14, pp. 159-162, ISSN:1424-8247 DOI Accesso ONLINE all'editore

Basile, Debora; Simionato, Francesca; Calvetti, Lorenzo; Cappetta, Alessandro; Pesavento, Annalisa; Mongillo, Marta; Roviello, Giandomenico; Rosati, Gerardo; Rossi, Gemma; Aprile, Giuseppe (2021). Comparing immunotherapies to other frequently used treatments of gastric cancer. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, vol. 14, pp. 1221-1232, ISSN:1751-2433 DOI Accesso ONLINE all'editore

Stellato, Marco; Santini, Daniele; Verzoni, Elena; De Giorgi, Ugo; Pantano, Francesco; Casadei, Chiara; Fornarini, Giuseppe; Maruzzo, Marco; Sbrana, Andrea; Di Lorenzo, Giuseppe; Soraru, Mariella; Naglieri, Emanuele; Buti, Sebastiano; De Vivo, Rocco; Napolitano, Andrea; Vignani, Francesca; Mucciarini, Claudia; Grillone, Francesco; Roviello, Giandomenico; Di Napoli, Marilena; Procopio, Giuseppe (2021). Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b). FRONTIERS IN ONCOLOGY, vol. 11, pp. 682449-682456, ISSN:2234-943X DOI Accesso ONLINE all'editore

Roviello G.; Aprile G.; D'Angelo A.; Iannone L.F.; Roviello F.; Polom K.; Mini E.; Catalano M. (2021). Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand?. GASTRIC CANCER, vol. 24, pp. 765-779, ISSN:1436-3291 DOI

Catalano M.; Casadei-Gardini A.; Vannini G.; Campani C.; Marra F.; Mini E.; Roviello G. (2021). Lenvatinib: established and promising drug for the treatment of advanced hepatocellular carcinoma. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, vol. 14, pp. 1353-1365, ISSN:1751-2433 DOI

Roviello G.; Rodriquenz M.G.; Aprile G.; D'Angelo A.; Roviello F.; Nobili S.; Mini E.; Sarno I.; Polom K. (2021). Maintenance in gastric cancer: New life for an old issue?. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 160, pp. 103307-103315, ISSN:1040-8428 DOI

Lavacchi D.; Roviello G.; Giommoni E.; Dreoni L.; Derio S.; Brugia M.; Amedei A.; Pillozzi S.; Antonuzzo L. (2021). Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience. CANCERS, vol. 13, pp. 3863-3890, ISSN:2072-6694 DOI

Cappellesso R.; Nozzoli F.; Marino F.Z.; Simi S.; Castiglione F.; De Giorgi V.; Cota C.; Senetta R.; Scognamiglio G.; Anniciello A.M.; Cesinaro A.M.; Mandala M.; Gianatti A.; Valente M.G.; Valeri B.; Sementa A.R.; Ricci C.; Corti B.; Roviello G.; Dei Tos A.P.; Franco R.; Massi D. (2021). Ntrk gene fusion detection in atypical spitz tumors. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 22, pp. 12332--, ISSN:1661-6596 DOI

Tartarone A.; Lapadula V.; Di Micco C.; Rossi G.; Ottanelli C.; Marini A.; Giorgione R.; Ferrari K.; Catalano M.; Voltolini L.; Mini E.; Roviello G. (2021). Beyond Conventional: The New Horizon of Targeted Therapy for the Treatment of Advanced Non Small Cell Lung Cancer. FRONTIERS IN ONCOLOGY, vol. 11, pp. 0-0, ISSN:2234-943X DOI

Giommoni, Elisa; Giorgione, Roberta; Paderi, Agnese; Pellegrini, Elisa; Gambale, Elisabetta; Marini, Andrea; Antonuzzo, Andrea; Marconcini, Riccardo; Roviello, Giandomenico; Matucci-Cerinic, Marco; Capaccioli, David; Pillozzi, Serena; Antonuzzo, Lorenzo (2021). Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients. IMMUNO, vol. 1, pp. 253-263, ISSN:2673-5601 DOI

Spinelli, Sara; Mini, Enrico; Monteleone, Erminio; Angiolini, Catia; Roviello, Giandomenico (2021). ALTERTASTE: improving food pleasure and intake of oncology patients receiving chemotherapy. FUTURE ONCOLOGY, pp. 0-0, ISSN:1479-6694 DOI Accesso ONLINE all'editore

Sobhani N.; Neeli P.K.; D'angelo A.; Pittacolo M.; Sirico M.; Galli I.C.; Roviello G.; Nesi G. (2021). AR-V7 in metastatic prostate cancer: A strategy beyond redemption. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 22, pp. 5515-5515, ISSN:1661-6596 DOI

Giorgione, Roberta; Santini, Daniele; Stellato, Marco; Basso, Umberto; Bimbatti, Davide; Palmieri, Valeria Emma; Doni, Laura; Antonuzzo, Lorenzo; Bersanelli, Melissa; Buti, Sebastiano; De Giorgi, Ugo; Galli, Luca; Sbrana, Andrea; Conca, Raffaele; Carella, Claudia; Naglieri, Emanuele; Mini, Enrico; Pignata, Sandro; Procopio, Giuseppe; Roviello, Giandomenico (2021). Active therapy or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The BEYOND study (Meet-Uro 19). JOURNAL OF CLINICAL ONCOLOGY, vol. 39, pp. 319-319, ISSN:0732-183X DOI

Rubino R, Marini A, Roviello G, Presotto EM, Desideri I, Ciardetti I, Brugia M, Pimpinelli N, Antonuzzo L, Mini E, Livi L, Maggi M, Peri A. (2021). Endocrine-related adverse events in a large series of cancer patients treated with anti-PD1 therapy. ENDOCRINE, vol. 74, pp. 172-179, ISSN:1559-0100 DOI

Roviello G.; Catalano M.; Santi R.; Palmieri V.E.; Vannini G.; Galli I.C.; Buttitta E.; Villari D.; Rossi V.; Nesi G. (2021). Immune checkpoint inhibitors in urothelial bladder cancer: State of the art and future perspectives. CANCERS, vol. 13, pp. 4411-4413, ISSN:2072-6694 DOI

Spatafora P.; Sessa F.; Caroassai Grisanti S.; Bisegna C.; Saieva C.; Roviello G.; Polverino P.; Rivetti A.; Verdelli L.; Zanazzi M.; Beatrice D.; Vignolini G.; Nesi G.; Nicita G.; Serni S.; Villari D. (2021). Prostate Cancer Characteristics in Renal Transplant Recipients: A 25-Year Experience From a Single Centre. FRONTIERS IN SURGERY, vol. 8, pp. 716861-716864, ISSN:2296-875X DOI

Basile, Debora; Simionato, Francesca; Cappetta, Alessandro; Garattini, Silvio Ken; Roviello, Giandomenico; Aprile, Giuseppe (2021). State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer. BIOLOGICS, vol. 15, pp. 451-462, ISSN:1177-5491 DOI Accesso ONLINE all'editore

Cattrini, Carlo; Messina, Carlo; Airoldi, Chiara; Buti, Sebastiano; Roviello, Giandomenico; Mennitto, Alessia; Caffo, Orazio; Gennari, Alessandra; Bersanelli, Melissa (2021). Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis. THERAPEUTIC ADVANCES IN UROLOGY, vol. 13, pp. 1-10, ISSN:1756-2872 DOI

Farsimadan, Marziye; Riahi, Seyed Mohammad; Muhammad, Huda Muhaddien; Emamvirdizadeh, Alireza; Tabasi, Mohsen; Motamedifar, Mohammad; Roviello, Giandomenico (2021). The effects of hepatitis B virus infection on natural and IVF pregnancy: A meta-analysis study. JOURNAL OF VIRAL HEPATITIS, vol. 28, pp. 1234-1245, ISSN:1352-0504 DOI Accesso ONLINE all'editore

Giandomenico Roviello, Roberto Petrioli, Donata Villari, Alberto D’Angelo (2020). Treating De Novo Metastatic Castration-Sensitive Prostate Cancer With Visceral Metastases: An Evolving Issue. CLINICAL GENITOURINARY CANCER, pp. 0-0, ISSN:1558-7673 DOI

D'Angelo, Alberto; Sobhani, Navid; Chapman, Robert; Bagby, Stefan; Bortoletti, Carlotta; Traversini, Mirko; Ferrari, Katia; Voltolini, Luca; Darlow, Jacob; Roviello, Giandomenico (2020). Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies. CANCERS, vol. 12, pp. 1-18, ISSN:2072-6694 DOI

Roviello G.; Villari D.; Roudi R. (2020). Immunotherapy-based combinations versus standard first-line and hypothyroidism risk. CLINICAL & TRANSLATIONAL ONCOLOGY, vol. 22, pp. 1664-1665, ISSN:1699-048X DOI

Cwalinski, Tomasz; Polom, Wojciech; Marano, Luigi; Roviello, Giandomenico; D'Angelo, Alberto; Cwalina, Natalia; Matuszewski, Marcin; Roviello, Franco; Jaskiewicz, Janusz; Polom, Karol (2020). Methylene Blue-Current Knowledge, Fluorescent Properties, and Its Future Use. JOURNAL OF CLINICAL MEDICINE, vol. 9, pp. 3538-3549, ISSN:2077-0383 DOI Accesso ONLINE all'editore

Rodriquenz, Maria Grazia; Roviello, Giandomenico; D'Angelo, Alberto; Lavacchi, Daniele; Roviello, Franco; Polom, Karol (2020). MSI and EBV Positive Gastric Cancer's Subgroups and Their Link With Novel Immunotherapy. JOURNAL OF CLINICAL MEDICINE, vol. 9, pp. 1427-1439, ISSN:2077-0383 DOI Accesso ONLINE all'editore

Lavacchi, Daniele; Roviello, Giandomenico; Rodriquenz, Maria Grazia (2020). Electronic nicotine delivery systems (ENDS): not still ready to put on END. JOURNAL OF THORACIC DISEASE, vol. 12, pp. 3857-3865, ISSN:2072-1439 DOI Accesso ONLINE all'editore

Sobhani, Navid; Corona, Silvia P; Roviello, Giandomenico; Bagby, Stefan; D'Angelo, Alberto; Iezzi, Giandomenico; Generali, Daniele (2020). Immune-gene signature: a new tool for patient selection for checkpoint inhibitors?. FUTURE ONCOLOGY, vol. 16, pp. 1327-1330, ISSN:1479-6694 DOI Accesso ONLINE all'editore

D'Angelo, Alberto; Bagby, Stefan; Galli, Ilaria Camilla; Bortoletti, Carlotta; Roviello, Giandomenico (2020). Overview of the clinical use of erdafitinib as a treatment option for the metastatic urothelial carcinoma: where do we stand. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, vol. 13, pp. 1139-1146, ISSN:1751-2433 DOI Accesso ONLINE all'editore

D'Angelo, Alberto; Sobhani, Navid; Bagby, Stefan; Casadei-Gardini, Andrea; Roviello, Giandomenico (2020). Cabozantinib as a second-line treatment option in hepatocellular carcinoma. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, vol. 13, pp. 623-629, ISSN:1751-2433 DOI Accesso ONLINE all'editore

Roviello, Giandomenico; Panella, Benedetta (2020). How the CARD trial has changed the cards on the table for metastatic castration resistant prostate cancer. REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, vol. 25, pp. 701-702, ISSN:1507-1367 DOI Accesso ONLINE all'editore

Roviello, Giandomenico; Conca, Raffaele; D'Angelo, Alberto; Multari, Andrea Giovanni; Paganini, Giovanni; Chiriacò, Giorgio; Petrioli, Roberto; Corona, Silvia Paola; Rosellini, Pietro; Aieta, Michele (2020). Association between neutropenia and response to ramucirumab and paclitaxel in patients with metastatic gastric cancer. ANTI-CANCER DRUGS, vol. 31, pp. 632-636, ISSN:0959-4973 DOI Accesso ONLINE all'editore

Roudi, Raheleh; Barodabi, Mahboubeh; Madjd, Zahra; Roviello, Giandomenico; Corona, Silvia Paola; Panahei, Mahshid (2020). Expression patterns and clinical significance of the potential cancer stem cell markers OCT4 and NANOG in colorectal cancer patients. MOLECULAR & CELLULAR ONCOLOGY, vol. 7, pp. 1788366-1788371, ISSN:2372-3556 DOI Accesso ONLINE all'editore

Catalano, Martina; Conca, Raffaele; Petrioli, Roberto; Ramello, Monica; Roviello, Giandomenico (2020). FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer. CANCER MANAGEMENT AND RESEARCH, vol. 12, pp. 10271-10278, ISSN:1179-1322 DOI Accesso ONLINE all'editore

Roviello, Giandomenico; Catalano, Martina; Nobili, Stefania; Santi, Raffaella; Mini, Enrico; Nesi, Gabriella (2020). Focus on Biochemical and Clinical Predictors of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Where Do We Stand?. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 21, pp. 7935-7943, ISSN:1422-0067 DOI

Roviello G.; Ramello M.; Catalano M.; D'Angelo A.; Conca R.; Gasperoni S.; Dreoni L.; Petrioli R.; Ianza A.; Nobili S.; Aieta M.; Mini E. (2020). Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer. SCIENTIFIC REPORTS, vol. 10, pp. 19281-19289, ISSN:2045-2322 DOI

Maruzzo, Marco; Verzoni, Elena; Pierantoni, Francesco; Galli, Luca; Vignani, Francesca; Buti, Sebastiano; Pignata, Sandro; Zanardi, Elisa; Sbrana, Andrea; Procopio, Giuseppe; Zivi, Andrea; Zielli, Teresa; Mini, Enrico; Roviello, Giandomenico; Basso, Umberto; Zagonel, Vittorina (2020). Prognostic role of T3/T4 ratio in metastatic renal cell carcinoma (mRCC): Preliminary results of the threeFOUR multicenter study (Meet-Uro 14). JOURNAL OF CLINICAL ONCOLOGY, vol. 38, pp. e17093-e17093, ISSN:0732-183X DOI

Roviello G.; Fancelli S.; Gatta Michelet M.R.; Aprile G.; Nobili S.; Roviello F.; Cianchi F.; Mini E.; Lavacchi D. (2020). TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 152, pp. 1-9, ISSN:1040-8428 DOI

D'Angelo A.; Bagby S.; Di Pierro G.; Chirra M.; Nobili S.; Mini E.; Villari D.; Roviello G. (2020). An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC). CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 149, pp. 10921-10921, ISSN:1040-8428 DOI

Roviello G.; Corona S.P.; D'angelo A.; Rosellini P.; Nobili S.; Mini E. (2020). Immune checkpoint inhibitors in pre-treated gastric cancer patients: Results from a literature-based meta-analysis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 21, pp. 448-448, ISSN:1661-6596 DOI

Roviello G.; Roviello F.; Mini E. (2020). Perioperative chemotherapy for gastric cancer in FLOT4. THE LANCET, vol. 395, pp. e3-E3, ISSN:0140-6736 DOI

Salati M.; Filippi R.; Vivaldi C.; Caputo F.; Leone F.; Salani F.; Cerma K.; Aglietta M.; Fornaro L.; Sperti E.; Di Maio M.; Ortega C.; Fenocchio E.; Lombardi P.; Cagnazzo C.; Depetris I.; Gelsomino F.; Spallanzani A.; Santini D.; Silvestris N.; Aprile G.; Roviello G.; Scartozzi M.; Cascinu S.; Casadei-Gardini A. (2020). The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer. LIVER INTERNATIONAL, vol. 40, pp. 704-711, ISSN:1478-3223 DOI

Roviello G.; Sobhani N.; Corona S.P.; D'Angelo A. (2020). Corticosteroid switch after progression on abiraterone acetate plus prednisone. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, vol. 25, pp. 240-246, ISSN:1341-9625 DOI

Lavacchi D.; Fancelli S.; Michelet M.R.G.; Catalano M.; Roviello G. (2020). REBECA trial: A new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer. TRANSLATIONAL CANCER RESEARCH, vol. 9, pp. 402-404, ISSN:2218-676X DOI

Lavacchi D.; Roviello G.; D'Angelo A. (2020). Tumor-Agnostic Treatment for Cancer: When How is Better than Where. CLINICAL DRUG INVESTIGATION, vol. 40, pp. 519-527-527, ISSN:1173-2563 DOI

Roviello G.; Villari D.; Nesi G.; Detti B. (2020). Radiotherapy after prostatectomy in high‑risk prostate cancer. CLINICAL & TRANSLATIONAL ONCOLOGY, pp. 001-002, ISSN:1699-048X DOI

Roviello G.; D'Angelo A.; Sciortino M.; Mini E.; Nobili S.; De Logu F.; Massi D. (2020). TRK fusion positive cancers: From first clinical data of a TRK inhibitor to future directions. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 152, pp. 0-0, ISSN:1040-8428 DOI

Sahlolbei, Maryam; Dehghani, Mohsen; Kheiri Yeghane Azar, Behghat; Vafaei, Somayeh; Roviello, G; D'Angelo, Alberto; Madjd, Zahra; Kiani, Jafar (2020). Evaluation of targetable biomarkers for chimeric antigen receptor T-cell (CAR-T) in the treatment of pancreatic cancer: a systematic review and meta-analysis of preclinical studies. INTERNATIONAL REVIEWS OF IMMUNOLOGY, vol. 39, pp. 223-232, ISSN:0883-0185 DOI Accesso ONLINE all'editore

Giandomenico Roviello, Alberto D'Angelo, Roberto Petrioli, Franco Roviello, Fabio Cianchi, Stefania Nobili, Enrico Mini, Daniele Lavacchi (2020). Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. TRANSLATIONAL ONCOLOGY, pp. 0-0, ISSN:1936-5233 DOI

GIULIO FRANCOLINI, BEATRICE DETTI, MATTEO MARIOTTI, GABRIELLA NESI, GIANDOMENICO ROVIELLO, PIETRO SPATAFORA, ISACCO DESIDERI, DONATA VILLARI, LORENZO LIVI (2020). In reply to Egger et al.: Lack of benefit from adjuvant postoperative radiotherapy and issues raised about upfront management of high- and very-high-risk prostate cancer patients. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, vol. 64, pp. 595-596, ISSN:1754-9477 DOI Accesso ONLINE all'editore

Catalano, Martina; Roviello, Giandomenico; Conca, Raffaele; D’Angelo, Alberto; Palmieri, Valeria Emma; Panella, Benedetta; Petrioli, Roberto; Ianza, Anna; Nobili, Stefania; Mini, Enrico; Ramello, Monica (2020). Clinical outcomes and safety of patients treated with NAb-Paclitaxel plus Gemcitabine in metastatic pancreatic cancer: the NAPA study. CURRENT CANCER DRUG TARGETS, vol. 20, pp. 0-0, ISSN:1568-0096 DOI Accesso ONLINE all'editore

Roviello G.; Casadei-Gardini A.; Nobili S.; Mini E.; Fancelli S. (2020). Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment. JOURNAL OF ONCOLOGY, vol. 2020, pp. 1-4, ISSN:1687-8450 DOI

Nobili, Stefania; Lavacchi, Daniele; Perrone, Gabriele; Vicini, Giulio; Tassi, Renato; Landini, Ida; Grosso, AnnaMaria; Roviello, Giandomenico; Mazzanti, Roberto; Santomaggio, Carmine; Mini, Enrico (2020). Vinorelbine in non-small cell lung cancer: Real-World data from a single institution experience. ONCOLOGY RESEARCH, pp. 237-248, ISSN:0965-0407 DOI

Nobili S, Lapucci A, Landini I, Coronnello M, Roviello G, Mini E. (2020). Role of ATP-binding cassette transporters in cancer initiation and progression. SEMINARS IN CANCER BIOLOGY, pp. 72-95, ISSN:1044-579X DOI

Roviello G.; Generali D.; Sobhani N. (2019). The combination of bevacizumab with chemotherapy is more beneficial in the metastatic setting rather than in the adjuvant setting for the treatment of HER2-negative breast cancer—a commentary on the E5103 randomized phase III clinical study. TRANSLATIONAL CANCER RESEARCH, vol. 8, pp. S94-S96, ISSN:2218-676X DOI Accesso ONLINE all'editore

Roviello G.; D'Angelo A.; Generali D.; Pittacolo M.; Ganzinelli M.; Iezzi G.; De Manzini N.; Sobhani N. (2019). Avelumab in gastric cancer. IMMUNOTHERAPY, vol. 11, pp. 759-768, ISSN:1750-743X DOI Accesso ONLINE all'editore

Roviello G.; Generali D.; Ianza A. (2019). Optimal primary end point in Phase II trials of immune checkpoint inhibitors for advanced solid cancers: An evolving issue. IMMUNOTHERAPY, vol. 11, pp. 365-368, ISSN:1750-743X DOI Accesso ONLINE all'editore

Roviello, Giandomenico; Corona, Silvia P; Multari, Andrea G; Petrioli, Roberto; Rosellini, Pietro; Aieta, Michele (2019). Poor outcome for patients with gastric cancer and lung metastases treated with ramucirumab and paclitaxel. ANTI-CANCER DRUGS, vol. 30, pp. e0789-748, ISSN:0959-4973 DOI

Sobhani N.; Roviello G.; Pivetta T.; Ianza A.; Bonazza D.; Zanconati F.; Giudici F.; Bottin C.; Corona S.P.; Guglielmi A.; Rizzardi C.; Milione M.; Cortale M.; Confalonieri M.; Generali D. (2019). Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma. MOLECULAR BIOLOGY REPORTS, vol. 46, pp. 2713-2720, ISSN:0301-4851 DOI

Roviello G.; Sohbani N.; Petrioli R.; Rodriquenz M.G. (2019). Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?. INVESTIGATIONAL NEW DRUGS, pp. 0000-0001, ISSN:0167-6997 DOI Accesso ONLINE all'editore

Afshari F.; Soleyman-Jahi S.; Keshavarz-Fathi M.; Roviello G.; Rezaei N. (2019). The promising role of monoclonal antibodies for gastric cancer treatment. IMMUNOTHERAPY, vol. 11, pp. 347-364, ISSN:1750-743X DOI Accesso ONLINE all'editore

Tartarone, Alfredo; Roviello, Giandomenico; Lerose, Rosa; Roudi, Raheleh; Aieta, Michele; Zoppoli, Pietro (2019). Anti-PD-1 versus anti-PD-L1 therapy in patients with pretreated advanced non-small-cell lung cancer: a meta-analysis. FUTURE ONCOLOGY, pp. 1-2, ISSN:1479-6694 DOI

Roviello G.; Corona S.P.; Aieta M.; Roudi R. (2019). Influence of Age and the Gleason Score in the Choice of Novel Hormonal Therapies before and after Chemotherapy. CANCER BIOTHERAPY & RADIOPHARMACEUTICALS, vol. 34, pp. 141-146, ISSN:1084-9785 DOI Accesso ONLINE all'editore

Roviello, Giandomenico; Corona, Silvia Paola; Conca, Raffaele; Petrioli, Roberto; Rosellini, Pietro; Bonetta, Alberto; Aieta, Michele (2019). Is there still a place for vinorelbine in advanced metastatic castration resistant prostate cancer?. MEDICINE, vol. 98, pp. e16249-2222, ISSN:0025-7974 DOI

Roviello, Giandomenico; D’Angelo, Alberto; Roudi, Raheleh; Petrioli, Roberto; Mini, Enrico (2019). Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than Lights. JOURNAL OF ONCOLOGY, vol. 2019, pp. 1-9, ISSN:1687-8450 DOI

Corona S.P.; Roviello G.; Strina C.; Milani M.; Madaro S.; Zanoni D.; Allevi G.; Aguggini S.; Cappelletti M.R.; Francaviglia M.; Azzini C.; Cocconi A.; Sirico M.; Bortul M.; Zanconati F.; Giudici F.; Rosellini P.; Meani F.; Pagani O.; Generali D. (2019). Efficacy of extended aromatase inhibitors for hormone-receptor–positive breast cancer: A literature-based meta-analysis of randomized trials. THE BREAST, vol. 46, pp. 19-24, ISSN:0960-9776 DOI Accesso ONLINE all'editore

Roviello G.; Petrioli R.; Rosellini P.; Multari A.G.; Conca R.; Paganini G.; Chiriaco G.; Aieta M. (2019). The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer. INVESTIGATIONAL NEW DRUGS, vol. 37, pp. 524-530, ISSN:0167-6997 DOI Accesso ONLINE all'editore

Roviello G.; Gallicchio R.; Bozza G.; Rodriquenz M.G.; Aieta M.; Storto G. (2019). Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223. ONCOTARGETS AND THERAPY, vol. 12, pp. 9-13, ISSN:1178-6930 DOI Accesso ONLINE all'editore

Yazdani M.; Angaji A.; Abolhasani M.; Fathi Z.; Madjd Z.; Roviello G.; Roudi R.; Asgari M. (2019). The relationship between KLK3 rs17632542 and PRNCR1 rs16901979 polymorphisms with susceptibility to prostate cancer. META GENE, vol. 21, pp. 100595-100596, ISSN:2214-5400 DOI Accesso ONLINE all'editore

Roviello G.; Generali D. (2019). New-Generation Hormone Therapies in Nonmetastatic Castration-Resistant Prostate Cancer: Why, Who, When. CLINICAL GENITOURINARY CANCER, vol. 17, pp. e534-e535, ISSN:1558-7673 DOI Accesso ONLINE all'editore

Roviello G, Conter FU, Mini E, Generali D, Traversini M, Lavacchi D, Nobili S, Sobhani N. (2019). Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer.. CANCER CHEMOTHERAPY AND PHARMACOLOGY, pp. 0-10, ISSN:0344-5704

Polom K; Das K; Marrelli D; Roviello G; Pascale V; Voglino C; Rho H; Tan P; Roviello F (2019). KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status. PATHOLOGY ONCOLOGY RESEARCH, vol. 25 (1), pp. 333-340, ISSN:1219-4956, SPRINGER: DOI Accesso ONLINE all'editore

Caraglia M.; Correale P.; Giannicola R.; Staropoli N.; Botta C.; Pastina P.; Nesci A.; Caporlingua N.; Francini E.; Ridolfi L.; Mini E.; Roviello G.; Ciliberto D.; Agostino R.M.; Strangio A.; Azzarello D.; Nardone V.; Falzea A.; Cappabianca S.; Bocchetti M.; D'Arrigo G.; Tripepi G.; Tassone P.; Addeo R.; Giordano A.; Pirtoli L.; Francini G.; Tagliaferri P. (2019). GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up. FRONTIERS IN ONCOLOGY, vol. 9, pp. 1102-1102, ISSN:2234-943X DOI

Chirra M.; Petrioli R.; Roviello G. (2019). Androgen receptor splice variant 7 in castration resistant prostate cancer treated with hormonal therapy: What is in the pipeline?. TRANSLATIONAL CANCER RESEARCH, vol. 8, pp. S595-S597, ISSN:2218-676X DOI

D'Angelo A.; Sobhani N.; Roviello G.; Bagby S.; Bonazza D.; Bottin C.; Giudici F.; Zanconati F.; De Manzini N.; Guglielmi A.; Generali D. (2019). Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma. PLOS ONE, vol. 14, pp. e0219566-e0219566, ISSN:1932-6203 DOI

Roviello, G; Gatta Michelet, M R; D'Angelo, A; Nobili, S; Mini, E (2019). Role of novel hormonal therapies in the management of non-metastatic castration-resistant prostate cancer: a literature-based meta-analysis of randomized trials. CLINICAL & TRANSLATIONAL ONCOLOGY, pp. 1-7, ISSN:1699-048X DOI

Roviello G.; Nobili S.; Mini E. (2019). A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical development. JOURNAL OF CHEMOTHERAPY, vol. 31, pp. 295-296, ISSN:1120-009X DOI Accesso ONLINE all'editore

Di Pierro, Giulia; Mini, Enrico; Roviello, Giandomenico (2019). Cabozantinib in advanced non-clear-cell renal cell carcinoma: is it the way clearer now?. ANNALS OF TRANSLATIONAL MEDICINE, vol. 7, pp. S229-S229, ISSN:2305-5839 DOI

Roviello G.; Corona S.P.; Nesi G.; Mini E. (2019). Results from a meta-analysis of immune checkpoint inhibitors in first-line renal cancer patients: does PD-L1 matter?. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, vol. 11, pp. 1-8, ISSN:1758-8340 DOI Accesso ONLINE all'editore

Lavacchi, Daniele; Mini, Enrico; Roviello, Giandomenico (2019). Abiraterone plus prednisone or enzalutamide in patients with metastatic castration-resistant prostate cancer: is a question of quality?. AME MEDICAL JOURNAL., vol. 4, pp. 24-26, ISSN:2520-0518 DOI

Sobhani, Navid; D'Angelo, Alberto; Pittacolo, Matteo; Roviello, Giandomenico; Miccoli, Anna; Corona, Silvia Paola; Bernocchi, Ottavia; Generali, Daniele; Otto, Tobias (2019). Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer. CELLS, vol. 8, pp. 321-322, ISSN:2073-4409 DOI

Roviello G.; Petrioli R.; Bonetta A.; Conca R.; Rodriquenz M.G.; Aieta M. (2018). Corticosteroid switch in heavily pre-treated castration-resistant prostate cancer patients progressed on abiraterone acetate plus prednisone. INVESTIGATIONAL NEW DRUGS, vol. 36, pp. 1110-1115, ISSN:0167-6997 DOI Accesso ONLINE all'editore

Roviello G.; Corona S.P.; Multari A.G.; Paganini G.; Chiriaco G.; Conca R.; Petrioli R.; Generali D.; Rosellini P.; Aieta M. (2018). Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer. ONCOTARGET, vol. 9, pp. 22332-22339, ISSN:1949-2553 DOI Accesso ONLINE all'editore

Sobhani N.; Generali D.; D'Angelo A.; Aieta M.; Roviello G. (2018). Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer. INVESTIGATIONAL NEW DRUGS, vol. 36, pp. 1133-1137, ISSN:0167-6997 DOI Accesso ONLINE all'editore

Roviello G.; Generali D.; Aieta M.; Bonetta A. (2018). Lower urinary tract infections from external beam radiation therapy in prostate cancer: A single institution experience. REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, vol. 23, pp. 298-299, ISSN:1507-1367 DOI Accesso ONLINE all'editore

Roviello G.; Imperatori M.; Aieta M.; Sollitto F.; Landriscina M. (2018). Adjuvant treatment for EGFR-mutated non-small cell lung cancer: Do we have a major breakthrough?. JOURNAL OF THORACIC DISEASE, vol. 10, pp. S2114-S2118, ISSN:2072-1439 DOI Accesso ONLINE all'editore

Sobhani, Navid; Ianza, Anna; D'Angelo, Alberto; Roviello, Giandomenico; Giudici, Fabiola; Bortul, Marina; Zanconati, Fabrizio; Bottin, Cristina; Generali, Daniele (2018). Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer. CELLS, vol. 7, pp. 76-77, ISSN:2073-4409 DOI

Roviello G.; Generali D. (2018). Pertuzumab therapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer. THE LANCET ONCOLOGY, vol. 19, pp. 1270-1272, ISSN:1470-2045 DOI Accesso ONLINE all'editore

Roviello G, Corona SP, Bozza G, Aieta M, Generali D, Rodriquenz MG, Mileo AM, Imperatori M, Ianza A, Conca R, Sobhani N. (2018). Lenvatinib for the treatment of renal cell carcinoma. EXPERT OPINION ON INVESTIGATIONAL DRUGS, vol. Volume 27, pp. 507-512, ISSN:1354-3784 DOI

Roviello G.; Petrioli R.; Nardone V.; Rosellini P.; Multari A.G.; Conca R.; Aieta M. (2018). Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer: Preliminary results of a phase II study. MEDICINE, vol. 97, pp. e10745-00000, ISSN:0025-7974 DOI Accesso ONLINE all'editore

Roviello G; Generali D. (2018). Is the fatigue an adverse event of the second generation of hormonal therapy? Data from a literature-based meta-analysis. MEDICAL ONCOLOGY, vol. 35, pp. -, ISSN:1357-0560 DOI

Polom, Karol; Marrelli, Daniele; Voglino, Costantino; Roviello, Giandomenico; De Franco, Lorenzo; Vindigni, Carla; Generali, Daniele; Roviello, Franco (2018). Familial aggregation of gastric cancer with microsatellite instability**. ACTA CHIRURGICA BELGICA, vol. 118, pp. 287-293, ISSN:0001-5458 DOI Accesso ONLINE all'editore

Polom, Karol; Marrelli, Daniele; Roviello, Giandomenico; Pascale, Valeria; Voglino, Costantino; Vindigni, Carla; Generali, Daniele; Roviello, Franco (2018). PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, vol. 27, pp. 963-969, ISSN:1899-5276 DOI Accesso ONLINE all'editore

Sobhani, Navid; Roviello, Giandomenico; CORONA, SILVIA; Scaltriti, Maurizio; Ianza, Anna; Bortul, Marina; Zanconati, Fabrizio; Generali, Daniele (2018). The prognostic value of PI3K mutational status in breast cancer: A meta-analysis. JOURNAL OF CELLULAR BIOCHEMISTRY, vol. 119, pp. 4287-4292, ISSN:0730-2312 DOI Accesso ONLINE all'editore

Polom, Karol; Marrelli, Daniele; Smyth, Elizabeth C; Voglino, Costantino; Roviello, Giandomenico; Pascale, Valeria; Varas, Julian; Vindigni, Carla; Roviello, Franco (2018). The Role of Microsatellite Instability in Positive Margin Gastric Cancer Patients. SURGICAL INNOVATION, vol. 25, pp. 99-104, ISSN:1553-3506 DOI

Polom, K.; Marano, L.; Marrelli, D.; De Luca, R.; Roviello, G.; Savelli, V.; Tan, P.; Roviello, F. (2018). Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer. BRITISH JOURNAL OF SURGERY, vol. 105, pp. 159-167, ISSN:0007-1323 DOI Accesso ONLINE all'editore

von Eyben FE; Roviello G; Kiljunen T; Uprimny C; Virgolini I; Kairemo K; Joensuu T. (2018). Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 45, pp. 496-508, ISSN:1619-7070 DOI

Pieraccini M.; Guerrini S.; Laiolo E.; Puliti A.; Roviello G.; Misuraca L.; Spargi G.; Limbruno U.; Breggia M.; Grechi M. (2018). Acute Massive and Submassive Pulmonary Embolism: Preliminary Validation of Aspiration Mechanical Thrombectomy in Patients with Contraindications to Thrombolysis. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, vol. 41, pp. 1840-1848, ISSN:0174-1551 DOI Accesso ONLINE all'editore

SOBHANI, NAVID; ROVIELLO, GIANDOMENICO; Corona, S. P.; IANZA, ANNA; ZANCONATI, FABRIZIO; GENERALI, DANIELE (2017). Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma. LUNG CANCER, vol. 114, pp. 103-105, ISSN:0169-5002 DOI Accesso ONLINE all'editore

ROVIELLO, GIANDOMENICO; Zanotti, Laura; Correale, Pierpaolo; Gobbi, Angela; Wigfield, Simon; GUGLIELMI, ALESSANDRA; Pacifico, Chiara; GENERALI, DANIELE (2017). Is still there a role for IL-2 for solid tumors other than melanoma or renal cancer?. IMMUNOTHERAPY, vol. 9, pp. 25-32, ISSN:1750-743X DOI Accesso ONLINE all'editore

Roviello G; Sobhani N; Generali D (2017). Bevacizumab in small cell lung cancer. ANNALS OF TRANSLATIONAL MEDICINE, pp. 0000-0001, ISSN:2305-5839

Corona S.P.; Sobhani N.; Ianza A.; Roviello G.; Mustacchi G.; Bortul M.; Zanconati F.; Generali D. (2017). Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5). MEDICAL ONCOLOGY, vol. 34, pp. 130-130, ISSN:1357-0560 DOI Accesso ONLINE all'editore

Milani, Manuela; Venturini, Sergio; Bonardi, Simone; Allevi, Giovanni; Strina, Carla; Cappelletti, Maria Rosa; Corona, Silvia Paola; Aguggini, Sergio; Bottini, Alberto; Berruti, Alfredo; Jubb, Adrian; Campo, Leticia; Harris, Adrian L.; Gatter, Kevin; Fox, Stephen B.; Generali, Daniele; Roviello, Giandomenico (2017). Hypoxia-related biological markers as predictors of epirubicinbased treatment responsiveness and resistance in locally advanced breast cancer. ONCOTARGET, vol. 8, pp. 78870-78881, ISSN:1949-2553 DOI Accesso ONLINE all'editore

ROVIELLO, GIANDOMENICO; Polom, K; Roviello, F; Marrelli, D; Multari, Ag; Paganini, G; Pacifico, C; GENERALI, DANIELE (2017). Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis. CANCER INVESTIGATION, vol. 35, pp. 187-194, ISSN:0735-7907 DOI Accesso ONLINE all'editore

Bonetta A; Generali D; Corona SP; Cancarini G; Brenna SG; Pacifico C; Roviello G (2017). Isolated Testicular Metastasis from Prostate Cancer. THE AMERICAN JOURNAL OF CASE REPORTS, vol. 18, pp. 887-889, ISSN:1941-5923 DOI Accesso ONLINE all'editore

ROVIELLO, GIANDOMENICO; Zanotti, Laura; Gobbi, Angela; Dester, Martina; GENERALI, DANIELE; Pacifico, Chiara; Cappelletti, Maria Rosa; Bonetta, Alberto (2017). Low-Dose Oral Ethinylestradiol With Concomitant Low-Dose Acetylsalicylic Acid for Advanced Castrate-Resistant Prostate Cancer. CLINICAL GENITOURINARY CANCER, vol. 15, pp. 371-375, ISSN:1558-7673 DOI Accesso ONLINE all'editore

ROVIELLO, GIANDOMENICO; Zanotti, Laura; Cappelletti, Maria Rosa; Gobbi, Angela; Dester, Martina; Paganini, Giovanni; Pacifico, Chiara; GENERALI, DANIELE; Roudi, Raheleh (2017). Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?. CLINICAL AND EXPERIMENTAL MEDICINE, pp. "-"-"-", ISSN:1591-8890 DOI Accesso ONLINE all'editore

Corona, Silvia Paola; Roviello, Giandomenico; Strina, Carla; Milani, Manuela; Allevi, Giovanni; Aguggini, Sergio; Zanoni, Daniele; Generali, Daniele (2017). Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer?. FUTURE ONCOLOGY, vol. 13, pp. 2473-2477, ISSN:1479-6694 DOI Accesso ONLINE all'editore

Corona, S. P.; SOBHANI, NAVID; IANZA, ANNA; ROVIELLO, GIANDOMENICO; MUSTACCHI, GIORGIO; BORTUL, MARINA; ZANCONATI, FABRIZIO; GENERALI, DANIELE (2017). Advances in systemic therapy for metastatic breast cancer: future perspectives. MEDICAL ONCOLOGY, vol. 34, pp. "-"-"-", ISSN:1357-0560 DOI Accesso ONLINE all'editore

Roviello, Giandomenico; Corona, Silvia Paola; Bonetta, Alberto; Cappelletti, Maria Rosa; Generali, Daniele (2017). Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer. ONCOTARGETS AND THERAPY, vol. 10, pp. 3811-3815, ISSN:1178-6930 DOI Accesso ONLINE all'editore

ROVIELLO, GIANDOMENICO; Bachelot, Thomas; Hudis, Clifford A.; Curigliano, Giuseppe; Reynolds, Andrew R.; Petrioli, Roberto; GENERALI, DANIELE (2017). The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials. EUROPEAN JOURNAL OF CANCER, vol. 75, pp. 245-258, ISSN:0959-8049 DOI Accesso ONLINE all'editore

von Eyben FE; Virgolini I; Roviello G (2017). Re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178-211. EUROPEAN UROLOGY, pp. -, ISSN:0302-2838

Sobhani N; Corona SP; Bonazza D; Ianza A; Pivetta T; Roviello G; Cortale M; Guglielmi A; Zanconati F; Generali D (2017). Advances in systemic therapy for malignant mesothelioma: future perspectives. FUTURE ONCOLOGY, vol. 13, pp. 2083-2101, ISSN:1479-6694 DOI Accesso ONLINE all'editore

De Manzoni, Giovanni; MARRELLI, DANIELE; Baiocchi, Gian Luca; Morgagni, Paolo; Saragoni, Luca; Degiuli, Maurizio; Donini, Annibale; Fumagalli, Uberto; MAZZEI, MARIA ANTONIETTA; Pacelli, Fabio; Tomezzoli, Anna; Berselli, Mattia; Catalano, Filippo; Di Leo, Alberto; Framarini, Massimo; Giacopuzzi, Simone; Graziosi, Luigina; Marchet, Alberto; MARINI, MARIO; Milandri, Carlo; Mura, Gianni; Orsenigo, Elena; Quagliuolo, Vittorio; Rausei, Stefano; Ricci, Riccardo; Rosa, Fausto; ROVIELLO, GIANDOMENICO; Sansonetti, Andrea; Sgroi, Giovanni; Tiberio, Guido Alberto Massimo; Verlato, Giuseppe; VINDIGNI, CARLA; Rosati, Riccardo; ROVIELLO, FRANCO (2017). The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. GASTRIC CANCER, vol. 20, pp. 20-30, ISSN:1436-3291 DOI Accesso ONLINE all'editore

ROVIELLO, GIANDOMENICO; Pacifico, Chiara; Corona, Paola; GENERALI, DANIELE (2017). Risk of hypertension with ramucirumab-based therapy in solid tumors: data from a literature based meta-analysis. INVESTIGATIONAL NEW DRUGS, vol. 35, pp. 518-523, ISSN:0167-6997 DOI Accesso ONLINE all'editore

Roviello G; Corona SP; Generali D (2017). Low dose versus standard dose of corticosteroids in the management of adverse events of special interest from abiraterone acetate: data from a literature-based meta-analysis. MEDICAL ONCOLOGY, vol. 34, pp. "-"-"-", ISSN:1357-0560 DOI Accesso ONLINE all'editore

Ravelli A1, 2; ROVIELLO, GIANDOMENICO; Cretella, D; Cavazzoni, A; Biondi, A; Cappelletti, Mr; ZANOTTI, LUCA; Ferrero, G; Ungari, M; ZANCONATI, FABRIZIO; Bottini, A; Alfieri, R; Petronini, Pg; GENERALI, DANIELE (2017). Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility. TUMOR BIOLOGY, vol. 39, pp. "-"-"-", ISSN:1010-4283 DOI Accesso ONLINE all'editore

Roviello G; Generali D (2017). Bevacizumab in small cell lung cancer. TRANSLATIONAL CANCER RESEARCH, pp. -, ISSN:2218-676X DOI

Sobhani, Navid; Generali, Daniele; Roviello, Giandomenico (2017). PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy. EBIOMEDICINE, vol. 22, pp. 18-19, ISSN:2352-3964 DOI Accesso ONLINE all'editore

Roviello G (2017). Role of PSA response as a marker for efficacy of patients with castration-resistant prostate cancer treated with novel hormonal therapies. THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, pp. -, ISSN:0393-6155

POLOM, KAROL ROMAN; MARRELLI, DANIELE; ROVIELLO, GIANDOMENICO; PASCALE, VALERIA; VOGLINO, COSTANTINO; Rho, Henry; MARINI, MARIO; MACCHIARELLI, RAFFAELE; ROVIELLO, FRANCO (2017). Molecular key to understand the gastric cancer biology in elderly patients—The role of microsatellite instability. JOURNAL OF SURGICAL ONCOLOGY, vol. 115, pp. 344-350, ISSN:0022-4790 DOI Accesso ONLINE all'editore

Polom, Karol; Marrelli, Daniele; ROVIELLO, GIANDOMENICO; Voglino, Costantino; Vindigni, Carla; GENERALI, DANIELE; Roviello, Franco (2017). Single Center Experience on Anatomy-and Histopathology-Based Gastric Cancer Molecular Classification. CANCER INVESTIGATION, vol. 35, pp. 325-332, ISSN:0735-7907 DOI Accesso ONLINE all'editore

ROVIELLO, GIANDOMENICO; Pacifico, C.; Polom, K.; Roviello, F.; GENERALI, DANIELE (2017). Different efficacy of ramucirumab in patients with metastatic gastric and gastroesophageal junction cancer according to ECOG performance status. ANNALS OF ONCOLOGY, vol. 28, pp. 665-666, ISSN:0923-7534 DOI Accesso ONLINE all'editore

Roviello, Giandomenico; Sobhani, Navid; Generali, Daniele (2017). Bevacizumab in small cell lung cancer. ANNALS OF TRANSLATIONAL MEDICINE, vol. 5, pp. "-"-"-", ISSN:2305-5839 DOI Accesso ONLINE all'editore

Roviello G; Generali D (2017). Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Data from a Literature-based Meta-analysis. EUROPEAN UROLOGY, vol. 72, pp. 1027-1028, ISSN:0302-2838 DOI Accesso ONLINE all'editore

BONETTA, ARIANNA; ROVIELLO, GIANDOMENICO; GENERALI, DANIELE; ZANOTTI, LUCA; Cappelletti, Mr; Pacifico, C; Di Pierro, F. (2017). Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma. RESEARCH AND REPORTS IN UROLOGY, vol. 9, pp. 65-69, ISSN:2253-2447 DOI Accesso ONLINE all'editore

ROVIELLO, GIANDOMENICO; GENERALI, DANIELE; Petrioli, Roberto (2017). Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033. EUROPEAN UROLOGY, pp. 1-2, ISSN:1873-7560 DOI Accesso ONLINE all'editore

Roviello G; Andre F; Venturini S; Pistilli B; Curigliano G; Cristofanilli M; Rosellini P; Generali D (2017). Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studies. EUROPEAN JOURNAL OF CANCER, vol. 86, pp. 257-265, ISSN:0959-8049 DOI Accesso ONLINE all'editore

ROVIELLO, GIANDOMENICO; Pacifico, Chiara; CHIRIACÒ, GIOVANNI; GENERALI, DANIELE (2017). Is still there a place for orteronel in management of prostate cancer? Data from a literature based meta-analysis of randomized trials. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 113, pp. 18-21, ISSN:1040-8428 DOI Accesso ONLINE all'editore

Roviello Giandomenico; Milani Manuela; Gobbi Angela; Dester Martina; Cappelletti Maria Rosa; Allevi Giovanni; Aguggini Sergio; Ravelli Andrea; Gussago Francesca; Cocconi Alessandra; Zanotti Laura; Senti Chiara; Strina Carla; Bottini Alberto; Generali Daniele (2016). A Phase II study of olaparib in breast cancer patients: Biological evaluation from a 'window of opportunity' trial. FUTURE ONCOLOGY, vol. 12, pp. 2189-2193, ISSN:1479-6694 DOI Accesso ONLINE all'editore

Roviello Giandomenico; Generali Daniele (2016). Is the Gleason score the driver for the treatment decision-making of patients with castration-resistant prostate cancer in the new era of the anti-androgenic therapies?. ANNALS OF ONCOLOGY, vol. 27, pp. 2131-2133, ISSN:0923-7534 DOI Accesso ONLINE all'editore

Roviello Giandomenico; Zanotti Laura; Venturini Sergio; Bottini Alberto; Generali Daniele (2016). Role of targeted agents in neuroendocrine tumors: Results from a meta-analysis. CANCER BIOLOGY & THERAPY, vol. 17, pp. 883-888, ISSN:1538-4047 DOI Accesso ONLINE all'editore

ROVIELLO, GIANDOMENICO; PETRIOLI, ROBERTO; Marano, Luigi; POLOM, KAROL ROMAN; MARRELLI, DANIELE; PERRELLA, ARMANDO; ROVIELLO, FRANCO (2016). Angiogenesis inhibitors in gastric and gastroesophageal junction cancer. GASTRIC CANCER, vol. 19, pp. 31-41, ISSN:1436-3291 DOI

ROVIELLO, Giandomenico; Milani, Manuela; Gobbi, Angela; Cappelletti, Maria Rosa; ZANOTTI, Laura; Senti, Chiara; BOTTINI, Alberto; STRINA, CARLA; SIGALA, Sandra; GENERALI, Daniele (2016). A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers. CLINICAL BREAST CANCER, vol. 16, pp. e57-e59, ISSN:1526-8209 DOI Accesso ONLINE all'editore

Roviello Giandomenico; Generali Daniele (2016). Is there a place for bevacizumab in patients with extensive-stage small cell lung cancer?. CURRENT CANCER DRUG TARGETS, vol. 16, pp. 209-214, ISSN:1568-0096 DOI Accesso ONLINE all'editore

Roviello Giandomenico; Ravelli Andrea; Barni Sandro; Petrelli Fausto; Bottini Alberto; Fox Stephen B.; Generali Daniele (2016). Is it time for everolimus-based combination in castration-resistant prostate cancer?. FUTURE ONCOLOGY, vol. 12, pp. 1849-1852, ISSN:1479-6694 DOI Accesso ONLINE all'editore

Roviello Giandomenico; Ravelli Andrea; Polom Karol; Petrioli Roberto; Marano Luigi; Marrelli Daniele; Roviello Franco; Generali Daniele (2016). Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer. CANCER LETTERS, vol. 372, pp. 187-191, ISSN:0304-3835 DOI Accesso ONLINE all'editore

POLOM, KAROL ROMAN; Marano, Luigi; ROVIELLO, GIANDOMENICO; PETRIOLI, ROBERTO; PIAGNERELLI, RICCARDO; DE FRANCO, LORENZO GIACINTO; MARRELLI, DANIELE; ROVIELLO, FRANCO (2016). Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence. INTERNATIONAL JOURNAL OF HYPERTHERMIA, vol. 32, pp. 173-179, ISSN:0265-6736 DOI

Roviello Giandomenico; Polom Karol; Petrioli Roberto; Marano Luigi; Marrelli Daniele; Paganini Giovanni; Savelli Vinno; Generali Daniele; De Franco Lorenzo; Ravelli Andrea; Roviello Franco (2016). Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives. TUMOR BIOLOGY, vol. 37, pp. 127-140, ISSN:1010-4283 DOI Accesso ONLINE all'editore

PETRIOLI, ROBERTO; ROVIELLO, GIANDOMENICO; Zanotti, Laura; ROVIELLO, FRANCO; POLOM, KAROL ROMAN; Bottini, Alberto; Marano, Luigi; Francini, Edoardo; MARRELLI, DANIELE; Generali, Daniele (2016). Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 102, pp. 82-88, ISSN:1040-8428 DOI Accesso ONLINE all'editore

Bonetta Alberto; Bandera Laura; Roviello Giandomenico; Cafaro Ines; Bottini Alberto; Generali Daniele (2016). Neoadjuvant chemotherapy and radical radiotherapy associated with cetuximab for laryngeal cancer in a pancreas and renal recipient. ANTI-CANCER DRUGS, vol. 27, pp. 470-473, ISSN:0959-4973 DOI Accesso ONLINE all'editore

Roviello Giandomenico; Ravelli Andrea; Fiaschi Anna Ida; Cappelletti Maria Rosa; Gobbi Angela; Senti Chiara; Zanotti Laura; Polom Karol; Reynolds Andrew R.; Fox Stephen B.; Generali Daniele (2016). Apatinib for the treatment of gastric cancer. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, vol. 10, pp. 887-892, ISSN:1747-4124 DOI Accesso ONLINE all'editore

Roviello Giandomenico; Borsella Giulia; Generali Daniele (2016). Expanding treatment options for metastatic gastric cancer. TRANSLATIONAL CANCER RESEARCH, vol. 5, pp. S22-S24, ISSN:2218-676X DOI Accesso ONLINE all'editore

POLOM, KAROL ROMAN; MARRELLI, DANIELE; PASCALE, VALERIA; ROVIELLO, GIANDOMENICO; VOGLINO, COSTANTINO; Rho, Henry; VINDIGNI, CARLA; MARINI, MARIO; MACCHIARELLI, RAFFAELE; ROVIELLO, FRANCO (2016). High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol. 142, pp. 1817-1824, ISSN:0171-5216 DOI

Roviello Giandomenico; Roviello Franco; Polom Karol; Generali Daniele (2016). Apatinib in metastatic gastric cancer: Can paclitaxel make the difference?. ANTI-CANCER DRUGS, vol. 27, pp. 809-809, ISSN:0959-4973 DOI Accesso ONLINE all'editore

Roviello Giandomenico; Zanotti Laura; Cappelletti Maria Rosa; Gobbi Angela; Senti Chiara; Bottini Alberto; Generali Daniele (2016). No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials. CLINICAL LUNG CANCER, vol. 17, pp. 334-340, ISSN:1525-7304 DOI Accesso ONLINE all'editore

Andreis, D.; BONARDI, MARIA SANTINA; Allevi, G.; Aguggini, S.; Gussago, F.; Milani, M.; Strina, C.; Spada, D.; Ferrero, G.; Ungari, M.; Rocca, A.; Nanni, O.; ROVIELLO, GIANDOMENICO; Berruti, A.; Harris, A. L.; Fox, S. B.; Roviello, F.; Polom, K.; Bottini, A.; GENERALI, DANIELE (2016). Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer. THE BREAST, vol. 29, pp. 55-61, ISSN:0960-9776 DOI Accesso ONLINE all'editore

MARRELLI, DANIELE; POLOM, KAROL ROMAN; PASCALE, VALERIA; VINDIGNI, CARLA; PIAGNERELLI, RICCARDO; DE FRANCO, LORENZO GIACINTO; FERRARA, FRANCESCO; ROVIELLO, GIANDOMENICO; GAROSI, LORENZO; PETRIOLI, ROBERTO; ROVIELLO, FRANCO (2016). Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer. ANNALS OF SURGICAL ONCOLOGY, vol. 23, pp. 943-950, ISSN:1068-9265 DOI

Marano, L; POLOM, KAROL ROMAN; Patriti, A; ROVIELLO, GIANDOMENICO; Falco, G; Stracqualursi, A; De Luca, R; PETRIOLI, ROBERTO; Martinotti, M; Generali, D; MARRELLI, DANIELE; Di Martino, N; ROVIELLO, FRANCO (2016). Surgical management of advanced gastric cancer: An evolving issue. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, vol. 42, pp. 18-27, ISSN:0748-7983 DOI Accesso ONLINE all'editore

ROVIELLO, Giandomenico; SIGALA, Sandra; Danesi, Romano; del Re, Marzia; BONETTA, ALBERTO; Cappelletti, Maria Rosa; ZANOTTI, Laura; BOTTINI, Alberto; GENERALI, Daniele (2016). Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 101, pp. 12-20, ISSN:1040-8428 DOI Accesso ONLINE all'editore

ROVIELLO, Giandomenico; SIGALA, Sandra; Sandhu, Shahneen; BONETTA, ALBERTO; Cappelletti, Maria Rosa; ZANOTTI, Laura; BOTTINI, Alberto; Sternberg, Cora N.; Fox, Stephen B.; GENERALI, Daniele (2016). Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials. EUROPEAN JOURNAL OF CANCER, vol. 61, pp. 111-121, ISSN:0959-8049 DOI Accesso ONLINE all'editore

De Franco L.; Marrelli D.; Caputo E.; Petrioli R.; Roviello G.; Calvanese A.; Roviello F. (2016). 28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, vol. 42, pp. S76-S76, ISSN:0748-7983 DOI

Roviello Giandomenico; Zanotti Laura; Cappelletti Maria Rosa; Gobbi Angela; Borsella Giulia; Pacifico Chiara; Multari Andrea Giovanni; Generali Daniele (2016). New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trials. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 108, pp. 62-68, ISSN:1040-8428 DOI Accesso ONLINE all'editore

PIAGNERELLI, RICCARDO; MARRELLI, DANIELE; ROVIELLO, GIANDOMENICO; FERRARA, FRANCESCO; DI MARE, GIULIO; VOGLINO, COSTANTINO; PETRIOLI, ROBERTO; MARINI, MARIO; Macchiarelli, Raffaele; ROVIELLO, FRANCO (2016). Clinical value and impact on prognosis of peri-operative CA 19-9 serum levels in stage I and II adenocarcinoma of the pancreas. TUMOR BIOLOGY, vol. 37, pp. 1959-1966, ISSN:1010-4283 DOI

Polom Karol; Roviello Giandomenico; Generali Daniele; Marano Luigi; Petrioli Roberto; Marsili Stefania; Caputo Edda; Marrelli Daniele; Roviello Franco (2016). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer. INTERNATIONAL JOURNAL OF HYPERTHERMIA, vol. 32, pp. 298-310, ISSN:0265-6736 DOI Accesso ONLINE all'editore

Roviello Giandomenico; Cappelletti Maria Rosa; Zanotti Laura; Gobbi Angela; Senti Chiara; Bottini Alberto; Ravelli Andrea; Bonetta Alberto; Paganini Giovanni; Generali Daniele (2016). Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials. MEDICINE, vol. 95, pp. ---, ISSN:0025-7974 DOI Accesso ONLINE all'editore

Francini E; Fiaschi Ai; Petrioli R; Laera L; Bianco V; Ponchietti R; Roviello G. (2015). Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience. ANTI-CANCER DRUGS, vol. 26, pp. 884-887, ISSN:0959-4973 DOI

Petrioli, Roberto; Roviello, Giandomenico; Laera, Letizia; Luzzi, Luca; Paladini, Piero; Ghiribelli, Claudia; Voltolini, Luca; Martellucci, Ignazio; Bianco, Vincenzo; Francini, Edoardo (2015). Cisplatin, Etoposide, and Bevacizumab Regimen Followed by Oral Etoposide and Bevacizumab Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer: A Single-Institution Experience. CLINICAL LUNG CANCER, vol. 16, pp. 229-234, ISSN:1525-7304 DOI Accesso ONLINE all'editore

Roviello G (2015). The distinctive nature of adenocarcinoma of the lung. ONCOTARGETS AND THERAPY, pp. 2399-2406, ISSN:1178-6930

MARANO, LUIGI; Chiari, Rita; Fabozzi, Alessio; De Vita, Ferdinando; Boccardi, Virginia; ROVIELLO, GIANDOMENICO; PETRIOLI, ROBERTO; MARRELLI, DANIELE; ROVIELLO, FRANCO; Patriti, Alberto (2015). C-Met targeting in advanced gastric cancer: An open challenge. CANCER LETTERS, vol. 365, pp. 30-36, ISSN:0304-3835 DOI Accesso ONLINE all'editore

PETRIOLI, ROBERTO; Francini, Edoardo; ROVIELLO, FRANCO; MARRELLI, DANIELE; MIANO, SALVATORA TINDARA; FIASCHI, ANNA IDA; LAERA, LETIZIA; BELLINI, MARCO ANTONIO; ROVIELLO, GIANDOMENICO (2015). Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status. JOURNAL OF GERIATRIC ONCOLOGY, vol. 6, pp. 380-386, ISSN:1879-4068 DOI

Petrioli R; Francini E; Fiaschi AI; Laera L; Roviello G (2015). Targeted Therapies for Prostate Cancer. CANCER INVESTIGATION, pp. 276-285, ISSN:0735-7907 DOI

Petrioli R; Francini E; Fiaschi AI; Laera L; Miano ST; De Rubertis G; Roviello G (2015). Reduced Dose of Abiraterone Acetate with Concomitant Low-dose Prednisone in the Treatment of ≥ 85 Year-old Patients with Advanced Castrate-resistant Prostate Cancer. ANTICANCER RESEARCH, pp. 3097-3102, ISSN:0250-7005

PETRIOLI, ROBERTO; ROVIELLO, GIANDOMENICO; FIASCHI, ANNA IDA; LAERA, LETIZIA; MARRELLI, DANIELE; ROVIELLO, FRANCO; Francini, Edoardo (2015). Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study. CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol. 75, pp. 683-690, ISSN:0344-5704 DOI

ROVIELLO, GIANDOMENICO; Francini, Edoardo; PERRELLA, ARMANDO; LAERA, LETIZIA; MAZZEI, MARIA ANTONIETTA; GUERRINI, SUSANNA; ROVIELLO, FRANCO; MARRELLI, DANIELE; PETRIOLI, ROBERTO (2015). Five years of stable disease with maintenance therapy using bevacizumab and tamoxifen in a patient with metastatic breast cancer. CANCER BIOLOGY & THERAPY, vol. 16, pp. 493-497, ISSN:1538-4047 DOI Accesso ONLINE all'editore

Francini E; Fiaschi AI; Petrioli R; Bianco V; Laera L; Francini F; Roviello G (2015). Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: final analysis of overall survival. ANTI-CANCER DRUGS, pp. 472-477, ISSN:0959-4973 DOI

Petrioli R; Roviello G; Fiaschi AI; Laera L; Roviello F; Marrelli D; Francini E (2015). Three-weekly oxaliplatin combined with gemcitabine and capecitabine in the first-line treatment of patients with advanced biliary tract cancer. ANTI-CANCER DRUGS, pp. 682-686, ISSN:0959-4973 DOI

Roviello G; Petrioli R; Laera L; Francini E (2015). The third line of treatment for metastatic prostate cancer patients: Option or strategy?. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, pp. 265-271, ISSN:1040-8428 DOI

Petrioli R; Francini E; Roviello G (2015). Is there still a place for docetaxel rechallenge in prostate cancer?. WORLD JOURNAL OF CLINICAL ONCOLOGY, pp. 99-103, ISSN:2218-4333 DOI

Roviello Giandomenico; Francini Edoardo; Perrella Armando; Laera Letizia; Mazzei Maria Antonietta; Guerrini Susanna; Petrioli Roberto (2015). An exceptional overall survival using bevacizumab beyond progression in a patient with Non-small cell lung cancer. CANCER BIOLOGY & THERAPY, vol. 16, pp. 1720-1725, ISSN:1538-4047 DOI

Petrioli R; Roviello G; Fiaschi Ai; Laera L; Bianco V; Ponchietti R; Barbanti G; Francini E. (2015). Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer. CLINICAL GENITOURINARY CANCER, vol. 13, pp. 441-446, ISSN:1558-7673 DOI

PETRIOLI, ROBERTO; Francini, Edoardo; ROVIELLO, FRANCO; MARRELLI, DANIELE; FIASCHI, ANNA IDA; LAERA, LETIZIA; ROSSI, GIULIA; Bianco, V; Brozzetti, S; ROVIELLO, GIANDOMENICO (2015). Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience. CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol. 75, pp. 941-947, ISSN:0344-5704 DOI

Petrioli R; Roviello G; Fiaschi AI; Laera L; Miano ST; De Rubertis G; Barbanti G; Bianco V; Brozzetti S; Francini E. (2015). Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experience. MEDICAL ONCOLOGY, pp. 52-52, ISSN:1357-0560 DOI

ROVIELLO, FRANCO; ROVIELLO, GIANDOMENICO; PETRIOLI, ROBERTO; MARRELLI, DANIELE (2015). Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 95, pp. 297-305, ISSN:1040-8428 DOI Accesso ONLINE all'editore

Petrioli R; Francini E; Ponchietti R; Roviello G; Laera L; Fiaschi Ai (2015). Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate. CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol. 76, pp. 439-445, ISSN:0344-5704 DOI

PETRIOLI, ROBERTO; ROVIELLO, GIANDOMENICO; FIASCHI, ANNA IDA; LAERA, LETIZIA; MIANO, SALVATORA TINDARA; MARRELLI, DANIELE; ROVIELLO, FRANCO; Bianco, Vincenzo; Francini, Edoardo (2015). Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer. FUTURE ONCOLOGY, vol. 11, pp. 2563-2574, ISSN:1479-6694 DOI

Petrioli R; Roviello G; Fiaschi AI; Laera L; Miano ST; Bianco V; Francini E (2015). Carboplatin, methotrexate, vinblastine, and epirubicin (M-VECa) as salvage treatment in patients with advanced bladder cancer: a phase II study. ANTI-CANCER DRUGS, pp. 878-883, ISSN:0959-4973 DOI

Petrioli, Roberto; Francini, Edoardo; Fiaschi, Anna Ida; Laera, Letizia; Luzzi, Luca; Paladini, Piero; Ghiribelli, Claudia; Voltolini, Luca; Bianco, Vincenzo; Roviello, Giandomenico (2015). Switch maintenance treatment with oral vinorelbine and bevacizumab after induction chemotherapy with cisplatin, gemcitabine and bevacizumab in patients with advanced non-squamous non-small cell lung cancer: a phase II study. MEDICAL ONCOLOGY, vol. 32, pp. 134-134, ISSN:1357-0560 DOI Accesso ONLINE all'editore

Francini E; Petrioli R; Fiaschi AI; Laera L; Roviello G (2014). Effects of abiraterone acetate on chronic kidney disease in 2 patients with metastatic castration-resistant prostate cancer. MEDICINE, pp. -, ISSN:0025-7974

Francini E; Roviello G (2014). How to optimize the sequential use of novel therapeutics in metastatic prostate cancer patients? Response should be found in prostate cancer tissue. TUMOR BIOLOGY, pp. -, ISSN:1010-4283

Francini E; Petrioli R; Roviello G (2014). No clear evidence of a clinical benefit of a sequential therapy regimen with abiraterone acetate and enzalutamide. EXPERT REVIEW OF ANTICANCER THERAPY, pp. -, ISSN:1473-7140

Francini E; Petrioli R; Rossi G; Laera L; Roviello G (2014). PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatments for patients with metastatic castration-resistant prostate cancer: an analysis of 22 trials. TUMOR BIOLOGY, pp. -, ISSN:1010-4283

Francini E; Fiaschi AI; Petrioli R; Francini F; Bianco V; Perrella A; Paganini G; Laera L; Roviello G (2014). Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer. ANTI-CANCER DRUGS, pp. -, ISSN:0959-4973

Francini E; Mazzaroppi S; Fiaschi AI; Petrioli R; Laera L; Roviello G; Pira T; Pellicelli AM; Bianco V (2014). Safety of sorafenib therapy in elderly adults with advanced hepatocellular carcinoma. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, pp. -, ISSN:0002-8614 DOI

Roviello G; Petrioli R; Francini E (2013). Time for a revision on the role of PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatment for patients with metastatic hormone-refractory prostate cancer. THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, pp. 326-328, ISSN:0393-6155

Roviello Giandomenico; Petrioli Roberto; Cerase Alfonso; Marsili Stefania; Miracco Clelia; Rubino Giovanni; Tini Paolo (2013). A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report. CASE REPORTS IN ONCOLOGY, vol. 6, pp. 538-543, ISSN:1662-6575 DOI

Petrioli R; Licchetta A; Roviello G; Pascucci A; Francini E; Bargagli G; Conca R; Miano ST; Marzocca G; Francini G; Multidisciplinary Oncology Group On Gastrointestinal Tumors (2012). CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab. CANCER INVESTIGATION, pp. 65-71, ISSN:0735-7907

Giandomenico ROVIELLO

Curriculum

From April 2023 to date

Associate Professor in Medical Oncology, Department of Health Sciences, Translational Oncology Unit, University of Florence, viale Pieraccini, 6, 50139, Florence, Italy

From February 2019 to March 2022

Assistant Professor in Medical Oncology, Department of Health Sciences, Translational Oncology Unit, University of Florence, viale Pieraccini, 6, 50139, Florence, Italy

From Sep. 2018 to January 2019

Medical Oncologist, Unit of medical oncology, Department of Oncology, University of Trieste, Piazza Ospitale 1, 34129 Trieste (TS), Italy

From Jen. 2018 to Aug. 2018

Medical Oncologist,Division of Medical Oncology, Department of Onco-Hematology, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero, Vulture (PZ), Italy

From Sep. 2016 to Dec. 2017

Research fellow and Medical Oncologist; Oncology Unit (Dr Bracarda Sergio), San Donato, Hospital Arezzo, Italy

From Sep. 2015 to Aug. 2016

Research fellow; University of Brescia, Unit of molecular therapy and pharmacogenomic, Breast Unit, ASST Cremona, Cremona, Italy

Education

Master di I level in Biostatistica per la Ricerca Clinica e la Pubblicazione Scientifica, University of Padova, year 2021-22

Master II level in Immuno Oncology, University of Rome La Sapienza, year 2020/21

PhD in Molecular Biomedicine, University of Trieste, year 2016/19

Specialization in Medical Oncology Residency Program, final degree mark 70/70 and lode, Università degli Studi di Siena, June 04 2015. Title of thesis: Rechallenge of Docetaxel combined with Epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to Docetaxel and Abiraterone Acetate

Post-graduate course in the field of Systemic revision and cochrane metanalysis, University of Modena and Reggio Emilia year 2014/15. Duration: 10 months

Post-graduate course in the field of Statistics applied to clinical question, University of Modena and Reggio Emilia year 2011/12. Duration: 10 months

Medical Licensure, registration at n° 6628 with Albo Professionale Medici Chirurghi della Provincia di Caserta (Caserta Medical Licensing Board), March 10 2009 - Present

Master's degree in Medicine and Surgery, final degree mark 108/110, Università degli Studi della Campania "Luigi Vanvitelli", July 23 2008. Title of thesis: Bortezomib in the treatment of multiple myeloma: a new therapeutic frontier.

High School Diploma, Liceo Scientifico “Armando Diaz”, Caserta, 2000